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DEVELOPMENT OF CHIMERIC TYPE IV SECRETION SYSTEMS FOR TRANSFER OF
HETEROLOGOUS SUBSTRATES ACROSS THE GRAM-NEGATIVE CELL ENVELOPE
Trista M. Berry, B.S.
Advisory Professor: Peter J. Christie, Ph.D.

Many bacteria use Type IV Secretion Systems (T4SSs) to aid in pathogenesis by
translocating virulence factors across the cell envelope and into eukaryotic cells. These
systems are structurally and functionally diverse, but are often compared to the archetypal
VirB/VirD4 T4SS of Agrobacterium tumefaciens. This system is composed of the VirD4 type
IV coupling protein (T4CP) and 11 VirB subunits (VirB1-11) that assemble as the secretion
channel and an extracellular pilus. The T4CP is an inner membrane ATPase that interacts
with T4SS substrates and the secretion channel, and is thought to link substrates with the
secretion channel and possibly energize transfer through the channel lumen. In this thesis, I
sought to adapt T4SSs in the surrogate hosts A. tumefaciens and Escherichia coli for use in
identification of novel T4SS effector proteins from genetically-intractable Rickettsial species.
I first constructed chimeric T4SSs in A. tumefaciens by substituting native VirD4 with
Rickettsial VirD4 homologs. However, I was unable to demonstrate transfer of the
promiscuous IncQ plasmid pML122 or known A. tumefaciens effector proteins. I next tested
the E. coli pKM101-encoded T4SS, which is known to transfer DNA substrates, for the
capacity to deliver heterologous protein substrates to E. coli recipients. Using the Crerecombinase reporter assay for translocation (CRAfT), I showed that pKM101 translocates
effector proteins from A. tumefaciens and two Rickettsial species, Anaplasma
phagocytophilum and Wolbachia pipientis. I next created chimeric T4CPs by joining the
transmembrane domain (TMD) of pKM101-encoded TraJ with the soluble domains (SDs) of
VirD4 homologs from A. tumefaciens and the Rickettsial species. I showed that all of these
chimeric systems translocate protein substrates, although less efficiently than the native
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pKM101 T4SS. Finally, I demonstrated that a variable C-terminal extension (CTE) that is
present on the A. tumefaciens and Rickettsial T4CPs plays a modulatory role for secretion
of different protein substrates. My findings showed for the first time that a T4SS encoded by
an E. coli conjugative plasmid is capable of translocating a variety of protein substrates from
phylogenetically diverse alphaproteobacterial species, including A. tumefaciens, A.
phagocytophilum, and W. pipientis.
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Protein

	
  

	
  
Introduction

Type 4 secretion systems are diverse and multi-functional
Many Gram-negative and Gram-positive bacteria use Type IV secretion systems
(T4SSs) to translocate virulence factors across the cell membrane(s) and into target cells to
aid in pathogenesis [1-3]. T4SSs are typically separated into three main subfamilies: (a)
conjugation systems that translocate DNA substrates between cells in a contact dependent
manner; (b) effector translocation systems that deliver protein substrates directly into target
cells; and (c) DNA uptake and release systems, known to move DNA to or from the
extracellular environment [1, 3, 4]. However, functionality of a specific system is not always
exclusive to one subfamily. For instance, Agrobacterium tumefaciens, of the class
Alphaproteobacteria, uses the prototypical VirB/VirD4 conjugative T4SS to deliver both
transfer DNA (T-DNA) and protein substrates (e.g., VirE2) into plant cells [4, 5] thereby
making it both a conjugative system and an effector translocation system. This T4SSmediated transfer of both T-DNA and protein effectors from A. tumefaciens causes the
formation of tumors on the plant, known as crown gall disease [3, 4].
T4SSs are diverse structurally and in the types of substrates they secrete. In A.
tumefaciens, the virB operon encodes all the subunits for assembly of the T4SS, including
the channel subunits VirB6-VirB10; the pilus subunits VirB2 and VirB5; and three ATPases
VirB4, VirB11 and VirD4 (Figure 1.1) [6]. Most T4SSs employed by Gram-negative bacteria
are composed of homologs of the VirB and VirD4 subunits, but there are many evolutionary
adaptations as well, resulting in T4SSs composed of additional subunits of unrelated
ancestries to the VirB/VirD4 subunits [7]. In Gram-positive bacteria, the T4SSs appear to be
minimized in the sense that they are composed principally of homologs or orthologs of A.
tumefaciens VirD4, VirB4, VirB1, VirB3, VirB6, and VirB8 [2].
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Figure 1.1 DNA transfer through the A. tumefaciens VirB/VirD4 Type IV Secretion
System.
The schematic shows the subcellular localizations of the VirD4 substrate receptor or T4CP
and two other ATPases VirB4 and VirB11, the channel subunits VirB6-VirB10, and the pilus
subunits VirB2 and VirB5. Also shown is the path of the DNA substrate, indicating a primary
interaction with the VirD4 coupling protein, followed by shuttling to the VirB11 ATPase, prior
to entering the secretion channel. OM, outer membrane, IM, inner membrane.
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VirD4: The substrate receptor
In 2004, our lab used an assay termed transfer-DNA immunoprecipitation (TrIP) to
experimentally describe the pathway of substrate secretion in A. tumefaciens [8]. Briefly, by
formaldehyde (FA) cross-linking proteins to the DNA substrate, followed by
immunoprecipitation of the Vir proteins, we identified T4SS subunits that formed an FAcrosslinkable contact with DNA as it exited the cell by PCR amplification. In order to
describe the pathway of substrate secretion, mutants lacking single virB or virD4 genes
were analyzed by TrIP; such mutations blocked DNA transfer at specific stages during
translocation. Using this methodology, it was established that VirD4 initially recruits the
relaxasome/T-DNA complex to the T4SS apparatus (Figure 1.1). From here, the substrate
is transferred to the VirB11 ATPase, then VirB6/B8 at the inner membrane, and finally
through a channel composed of the VirB2 and VirB9 subunits for passage through the
periplasm and outer membrane.
Much of the work in this thesis is focused on the type IV coupling protein (T4CP)
from A. tumefaciens, VirD4, and its homologs, including TraJ from the IncN plasmid pKM101
and the VirD4-like proteins from some Rickettsial species. In order to delineate the different
VirD4-like proteins, I will indicate the species of origin as a subscript (VirD4At, A.
tumefaciens; VirD4Ap, Anaplasma phagocytophilum; VirD4Wp, Wolbachia pipientis; and
VirD4Rr, Rickettsia rickettsii). VirD4 is an inner membrane ATPase that interacts with T4SS
substrates and is thought to energize the transfer of the substrate through the lumen of the
channel created by the other Vir proteins [1]. VirD4 is termed a coupling protein (or T4CP)
because it links the relaxosome, formed by the DNA transfer and replication (Dtr) proteins,
with the translocation channel and pilus, formed by the mating pair formation (Mpf) proteins
[1, 9]. It is suggested that the T4CP interaction with the Mpf proteins occurs via
transmembrane domains at the inner membrane, while recruitment and binding of the
relaxosome and associated Dtr proteins occurs via one or more domains comprising the
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soluble portion of the T4CP [9, 10]. VirD4-like coupling proteins are associated with most
T4SSs; those of interest to my thesis project include VirD4At, the Rickettsial T4CPs
mentioned above, and T4CPs encoded by E. coli conjugative plasmids including TrwBR388
[11], TraDF [12], and TraJpKM101 [10].
T4CPs generally consist of an N-terminal transmembrane domain (TMD), a
nucleotide binding domain (NBD), the all-alpha domain (AAD), and often a C-terminal
extension (CTE) (Figure 1.2) [11]. The T4CP from E. coli plasmid R388, TrwB, is the
structural paradigm for all T4CPs. A soluble variant of TrwB has been crystallized as a
homohexamer with a central channel of approximately 20 Å in diameter [11, 13]. The
overall structure of TrwB, is that of an F1-FO ATPase-like ball-stem with the TMD having an
integral role in hexamer formation in addition to anchoring the T4CP within the inner
membrane [11, 13]. The TMD of the TrwB monomer consists of at least two transmembrane
helices that span the inner membrane [1], and is thought to be responsible for interaction of
the T4CP with the channel subunits [1, 11].
The NBD includes Walker A and B nucleoside triphosphate binding site motifs
characteristic of ATPases, and shares both structural and sequence similarities with E. coli
FtsK and Bacillus subtilis SpoIIIE [14]. FtsK and SpoIIIE are hexameric double-stranded (ds)
DNA translocases that bind and translocate chromosomal DNA during cell division or
sporulation. This movement of DNA is thought to occur through the central channel of the
hexameric ring and has led to proposals that the T4CPs may translocate DNA substrates
across the inner membrane in a similar manner [14, 15]. The AAD is a seven-helix bundle
positioned at the cytoplasmic end of the T4CP hexamer and bears structural similarity to the
XerD site-specific recombinase [11, 16]. Both its relative location in the T4CP and its
structural homology to a DNA-binding protein has lead to the suggestion that the AAD
participates in substrate recognition and delivery to the transfer channel.
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The specific interface for T4CP-substrate interaction has yet to be determined.
While the AAD might be involved in substrate docking, it is noteworthy that the AAD’s of
VirD4 homologs are generally closely related among different species of the
alphaproteobacteria, e.g., A. tumefaciens and Rickettsial spp. (Figure 1.3) [1], suggesting
that this domain alone does not mediate substrate specificity to cognate T4SSs. To better
define the domains contributing to T4SS substrate specificity, we constructed various T4CP
domain deletions and substitutions. Specifically, a postdoctoral fellow in the Christie lab, Dr.
N. Whitaker, determined that deletion of the AAD of pKM101-encoded TraJ abolished
plasmid transfer, indicating that this AAD may have a role in DNA substrate interactions
(See Chapter 5). Additionally, I determined that the C-terminal extension (CTE), which is
carried by a subset of the T4CPs, is highly variable (Figure 1.4) [1]. In Chapters 3 and 5, I
present data indicating that deletion of the CTE’s from T4CPs from A. tumefaciens
Rickettsial homologs alters translocation efficiencies of some protein substrates.
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A

TMD
VirD4At

B

1

AAD
88

201

NBD

346

Trans-membrane
Domain (TMD)

CTE
552

656

C-terminal
Extension (CTE)

All-alpha Domain
(AAD)
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(NBD)

Figure 1.2 VirD4 coupling protein (T4CP) domain structure
A. Schematic representation of the domain organization of A. tumefaciens VirD4.
Numbers depict residues marking the domain boundaries along the length of the
protein. TMD, transmembrane domain; AAD, all alpha domain; NBD, nucleotide
binding domain; CTE, C-terminal extension.
B.

Topology schematic of TrwB modified from Gomis-Ruth, et al. 2002.

This figure was modified to identify domains, but TrwB lacks a C-terminal extension
found in VirD4 and other T4CPs. Permission for use granted by the American
Society for Biochemistry and Molecular Biology.
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Figure 1.3 Sequence alignment of the all-alpha domains (AAD’s) of VirD4 homologs
AAD sequence alignment from different alphaproteobacteria under study in this thesis.
VirD4At, A.tumefaciens residues 201-346; VirD4Ap, A. phagocytophilum residues 218-351;
VirD4Wp, Wolbachia spp. residues 218-352; VirD4Rr, R. rickettsii residues 215-348.
Alignment shows high sequence conservation amongst the AAD’s, especially those of the
Rickettsial homologs. Red residues, high consensus (90%); blue residues, low consensus
(50%).
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Figure 1.4 Sequence alignment of the C-terminal extensions (CTE’s) of VirD4
homologs
CTE sequence alignment from different alphaproteobacteria under study in this thesis.
VirD4At, A.tumefaciens residues 552-656; VirD4Ap, A. phagocytophilum residues 573-740;
VirD4Wp, Wolbachia spp. residues 573-676; VirD4Rr, R. rickettsii residues 570-591.
Alignment shows almost no sequence conservation, high variability in domain length, and
over-representation of acidic residues. Blue residues, low consensus (50%).
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Chimeric T4SS as a study tool
A. tumefaciens is phylogenetically closely related to Rickettsial species, including
those of Anaplasma, Wolbachia, and Rickettsia genera [1, 7, 17]. In Rickettsiales, much of
the A. tumefaciens VirB/VirD4 T4SS is conserved, including many of the VirB1-VirB11
channel subunit proteins and the VirD4 T4CP [1, 17]. These Rickettsial T4SSs translocate
effector proteins into host cells to cause a variety of animal and human diseases, making
the study of these organisms medically important [1]. However, functional characterization
of Rickettsial T4SSs and the effectors translocated during infection have been hindered by
difficulties in cultivation of Rickettsial species in the lab and their genetic intractability.
Various approaches have been taken to identify novel effectors whose translocation
contributes to the virulence of species that are difficult to genetically manipulate, e.g.,
intracellular pathogens [18, 19]. Production of candidate effectors in surrogate hosts
followed by tests for T4SS translocation has supplied evidence for translocation of candidate
effectors of intracellular bacteria, as summarized by Alvarez-Martinez and Christie [1]. For
example, A. phagocytophilum AnkA was identified as a possible effector by demonstrating
its translocation through the A. tumefaciens VirB/D4 T4SS [20]. In this case, AnkA was
fused to the Cre recombinase and the fusion protein was shown to translocate through the
A. tumefaciens VirB/VirD4 T4SS into plant cells. Translocation was detected by engineering
plant cells to carry a GFP reporter gene that is interrupted by a DNA segment flanked by two
lox sites. Translocation of Cre-AnkA to plants resulted in Cre-mediated excision of the lox
cassette, allowing production of GFP in the plant. Similar surrogate systems have been
used to identify possible T4SS substrates of Coxiella burnetii [21], and Anaplasma
marginale [22].
Others have attempted using chimeric T4SSs to demonstrate transfer of noncognate substrates [9, 23]. These chimeric T4SSs produce a heterologous substrate
receptor along with the native VirB channel complex and have been shown to retain the
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capacity to translocate at least some substrates [1]. For example, a chimeric T4SS in
plasmid R388, producing the T4CP from RP4, was shown to functionally complement for
transfer of the mobilizable plasmid RSF1010 [23]. In this case, the authors found that the
native T4CP, TrwB, could complement an R388 trwB- strain of Escherichia coli for
translocation of the plasmid RSF1010. Additionally, the T4CP from RP4, TraG, was able to
complement the same strain at wild-type levels for RSF1010 transfer, but not for R388 selftransfer. This demonstrated that such chimeric T4SSs are limited in their functionality.

Significance
The current approaches being used to identify novel effectors using native hosts or
surrogate systems are often complicated by difficulties in genetic manipulation of the host
species or inefficiencies in effector recognition by surrogate systems [20-22]. The
overarching aim of this thesis project was to determine the capacity of two model and easily
manipulated T4SSs, one from A. tumefaciens and the second from E. coli, to serve as
surrogate hosts for translocation of candidate T4SS effectors of Rickettsial spp. A second
goal was to define the importance of the VirD4 CTE’s for substrate transfer. Although the
work presented utilizes known or previously identified substrates, the methods used should
allow for high-throughput screens to identify novel substrates.
In chapter 3, I present results of studies exploring the capacity of genes encoding
Rickettsial VirD4-like proteins to complement an A. tumefaciens virD4 null mutation for
transfer of A. tumefaciens effectors and a mobilizable IncQ plasmid, pML122. The
Rickettsial virD4 genes do not complement for translocation of A. tumefaciens effectors, but
their expression in an otherwise wild-type background confers dominant negative
phenotypes suggestive of disruptive interactions with other T4SS components. I also
defined the importance of VirD4’s CTE for substrate transfer in A. tumefaciens.
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In chapter 4, I explore use of the Tra T4SS encoded by E.coli plasmid pKM101 as a
surrogate system for translocating substrates shown or postulated to be translocated
through A. tumefaciens or Rickettsial spp. T4SSs. I collaborated with another student, Jay
Gordon, to create a nonpolar traJ deletion mutant using recombineering. Using this deletion
mutant, I demonstrated that while genes encoding Rickettsial VirD4 homologs do not
complement the ΔtraJ mutation for pKM101 self-transfer or for transfer of IncQ, they do
complement for transfer of some protein substrates. Additionally, I was able to establish the
ability of the wild-type pKM101 T4SS to translocate non-cognate substrates. These
discoveries are highly important, as this is the first demonstration of protein transfer in the
pKM101 system.
Finally, in chapter 5, I explore the functionality of chimeric T4CPs in mediating
substrate transfer through the pKM101 transfer system. These chimeric T4CPs are
composed of the TMD from TraJ and the soluble domain (SD) of the VirD4 homologs. The
hypothesis under investigation was that TraJ’s TMD would mediate a productive interaction
with pKM101’s T4SS channel, and the SD would recruit heterologous substrates for delivery
through the channel. Since the native pKM101 system was found to translocate
heterologous protein substrates, the goal of this line of work was to optimize translocation
efficiencies. I determined that some chimeric VirD4 proteins support protein transfer, and I
explored the roles of the CTE and AAD in mediating substrate transfer using the chimeric
systems.
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Chapter 2. Materials and Methods
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Bacterial strains and growth/induction conditions
All strains used are listed in Table 2.1. A. tumefaciens A348 and E. coli DH5α and
MS411 served as the wild-type strains for these studies [24-26]. Strain Mx355, a derivative
of A348 with a transposon insertion in virD4 [27], served as a virD4 null mutant. Plasmid
constructions were carried out with E. coli DH5α, as described below. Growth conditions of
A. tumefaciens cells have been previously described [28]. Briefly, strains are grown on
MG/L plates (Luria Bertani (LB) media supplemented with mannitol and glutamate) for 2
days at 28 °C [28, 29]. Colonies were inoculated into MG/L broth and grown overnight at
room temperature while shaking. Appropriate antibiotics were added for maintenance of
plasmids in the following concentrations: carbenicillin (100 µg/ml), kanamycin (100 µg/ml),
gentamicin (100 µg/ml), spectinomycin (200-400 µg/ml) [24, 30, 31]. For induction of vir
genes, cultures of A. tumefaciens strains were grown overnight with antibiotic selection, and
then 1 ml of the culture was pelleted and resuspended in ABIM (minimal media
supplemented with the inducer, acetosyringone (100 µM)) [32]. Cells were incubated for 1618 hours with shaking at room temperature.
E. coli strains were grown as previously described [25, 33]. Briefly, strains were
grown on LB plates overnight at 37 °C. Colonies were inoculated into LB broth and grown
overnight at 37 °C while shaking. Appropriate antibiotics were added in the following
concentrations unless noted otherwise: carbenicillin (100 µg/ml), kanamycin (50 µg/ml),
gentamicin (20 µg/ml), spectinomycin (100 µg/ml), tetracycline (20 µg/ml), chloramphenicol
(20 µg/ml) [24, 34]. For arabinose induction of genes encoding Cre-effector fusion proteins,
50 µl of overnight culture was inoculated into 5 ml LB broth and grown to mid-log phase
(OD600 ~0.4-0.6). Optical density readings were taken on a Beckman DU 530 UV/Vis
spectrophotometer. Cells were induced by addition of 0.2% arabinose and incubation with
shaking for 2-4 hrs. Cultures were normalized by OD600 and 1 ml of cells was used for
protein analysis.
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Table 2.1 Bacterial strains and plasmids
Strain or plasmid

Relevant characteristic(s)

Source

E. coli strains
DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1
hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λWM1650 CAG18477; Tet linked to priA(+)

CSH26Cm::LTL

Invitrogen
[35]

MS411 ilvG rfb-50 thi
r

Gibco-BRL/

[33]
r

Tet , CSH26 galK::cat::loxP-Tet-loxP; Cam after Cre

[33]

mediated excision at loxP sites
A. tumefaciens
strains
A348 A. tumefaciens containing octopine-type Ti plasmid

[26]

pTiA6NC
A348-Spcr Spcr; derivative of A348
Mx355 A348 derivative virD4::Tn3HoHo1

[36]
[27]

Vector plasmids
pBSKS

Crbr; cloning vector

Stratagene

pBSK

Crbr; cloning vector

Stratagene

pBSIIKS

+

r

Crb ; cloning vector

pBSIIKS+NdeI Crbr; cloning vector containing NdeI restriction site at the

Stratagene
[37]

translational start site of lacZ
pBBR1MCS2-Gen

R

Genr; broad-host-range cloning vector
r

pXZ151 Kan ; broad-host-range IncP derivative of pSW172

[38]
[39]

encoding a Kanr cassette
Genr; mobilizable IncQ derivative (RSF1010)

[40]

pUC4K

Kanr; source of cassette conferring Kanr

Amersham

pHP45Ω

Spcr; source of cassette conferring Spcr

[41]

pML122ΔKm

pBAD24 Crbr; pBR322/ColE1 expression vector inducible with

[42]

arabinose
pBAD24-Kanr Kanr, Crbs; gene conferring Kanr from pUC4K inserted in

This Study

the Crbr gene of pBAD24
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pKM101 Crbr; broad-host-range IncN plasmid derived from R46
pKM101-Spcr Spcr, Crbs; pKM101 with the cassette conferring Spcr

[43]
This Study

from pHP45Ω inserted into the Crbr gene at EcoRI
pKM101ΔtraJ Spcr, Crbs; pKM101-Spcr containing a clean deletion of

This Study

traJ
pBAD33 Camr; pACYC184/p15A expression plasmid inducible

[42]

with arabinose
pBAD33-Cre Camr; pBAD33 expressing Cre recombinase from an

This Study

arabinose inducible promoter
A. tumefaciens
Expression Plasmids
pPC914KS+ Crbr; pBSIIKS+ derivative expressing PvirB-virB1;

[44]

expression vector when substituting other genes for virB1
pXZ27 Crbr; pBSIIKS+NdeI expressing PvirB-virE2; expression

[39]

vector when substituting other genes for virE2
pZZ11 Crbr; pPC914KS+ expressing PvirB-GST
r

+

pKA9 Crb ; pBSIIKS expressing PvirB-virD4At

[37]
[45]

r

+

This Study

r

+

This Study

pTB7 Crb ; pPC914KS expressing PvirB-virD4Ap
pTB12 Crb ; pPC914KS expressing PvirB-virD4Wp
r

r

pTB19 Crb , Kan ; pTB12 ligated to pXZ151 for expression in A.

This Study

tumefaciens
pTB20 Crbr, Kanr; pTB7 ligated to pXZ151 for expression in A.

This Study

tumefaciens
pTB22 Crbr, Kanr; pKA9 ligated to pXZ151 for expression in A.

This Study

tumefaciens
pTB37 Crbr; pXZ27 expressing PvirB-virD4AtΔ553
r

r

pTB46 Crb , Kan ; pTB37 ligated to pXZ151 for expression in A.

This Study
This Study

tumefaciens
E. coli Expression
Plasmids

	
  

pTB25 Kanr; pBAD24-Kanr expressing virD4Wp from pTB12

This Study

pTB26 Kanr; pBAD24-Kanr expressing traJ from pKM101

This Study
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pTB47 Kanr; pBAD24-Kanr expressing virD4At from pKA9

This Study

pTB48 Kanr; pBAD24-Kanr expressing virD4Ap from pTB7

This Study

pTB49 Crbr; pBAD24 expressing virD4Rr

This Study

pNW5 Crbr; pBSIIKS+NdeI expressing virD4At from pKA9

This Study

pNW7 Crbr; traJΔAAD, containing a deletion of the all-alpha

This Study

domain, cloned into pBAD24
Chimeric virD4
plasmids
pTB38 Kanr; traJ::virD4Ap cloned into pMK-RQ as provided by

This Study,

Invitrogen

Invitrogen

r

This Study

r

This Study

r

This Study

pTB39 Crb ; pBAD24 expressing traJ::virD4Ap from pTB38
pTB50 Crb ; pBAD24 expressing traJ::virD4ApΔ574
pTB51 Crb ; pBAD24 expressing traJ::virD4Wp
r

pTB52 Crb ; pBAD24 expressing traJ::virD4WpΔ574
r

pNW1 Crb ; transmembrane domain of traJ cloned into pBSIIKS

This Study
+

This Study

r

This Study

r

This Study

pNW2 Crb ; soluble domain of virD4At cloned into pNW1
pNW4 Crb ; virD4AtΔ553 containing a C-terminal deletion at
residue 553 cloned into pNW1 generating
traJ::virD4AtΔ553
pNW6 Crbr; virD4At SDΔAAD containing a deletion of the all-

This Study

alpha domain cloned into pNW1 generating
traJ::virD4AtΔAAD
pNW10 Crbr; traJ::virD4At with the AAD of traJ cloned into
pBSIIKS

This Study

+

pNW11 Crbr; traJ with the AAD of virD4At cloned into pBAD24

This Study

Effector Plasmids
pTB30 Crbr; putative Anaplasma effector Aph_0111 cloned into
pBSK
pTB40 Camr; ats-1 cloned into pBAD33-Cre

This Study;
J. Carlyon1
This Study;
J.Carlyon1

pTB41 Camr; Aph_0111 from pTB30 subcloned into pBAD33-

This Study

Cre
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pTB42 Camr; ats-1 CTD cloned into pBAD33-Cre

This Study;
J.Carlyon1

pTB43 Camr; putative Wolbachia effector WD0636 cloned into
pBAD33-Cre
pTB44 Camr; putative Wolbachia effector WD0811 cloned into
pBAD33-Cre
pTB45 Camr; putative Wolbachia effector WD0830 cloned into
pBAD33-Cre
pTB53 Camr; virE3 cloned into pBAD33-Cre after PCR

This Study;
I. Newton2
This Study;
I. Newton2
This Study;
I. Newton2
This Study

amplificantion of the Ti plasmid
pTB54 Camr; virF cloned into pBAD33-Cre after PCR

This Study

amplification of the Ti plasmid
pTB55 Camr; virE2 from pXZ27 subcloned into pBAD33-Cre
1

This Study

Anaplamsa phagocytophilum genomic DNA provided by Jason Carlyon at Virginia

Commonwealth University; 2 Wolbachia pipientis putative effector genes provided by Irene
Newton at Indiana University, all were received in pENTR-D/TOPO vectors and PCR
amplified for cloning.
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Plasmid constructions
Plasmids used in this study are listed in Table 2.1 and primers used for PCR are
listed in Table 2.2. The vector plasmid pBAD24-Kanr was made by isolation of a gene
conferring kanamycin resistance as a HincII fragment from pUC4K and insertion into the
single ScaI restriction site within pBAD24 [42]. The conjugative plasmid pKM101-Spcr was
made by isolation of a gene conferring spectinomycin resistance as an EcoRI fragment from
pHP45Ω and insertion into similarly digested pKM101. The resulting plasmid is Spcr and
Crbs and retains all of its conjugative abilities.
Plasmid pTB7 expresses the A. phagocytophilum virD4 homolog (virD4Ap) from the
PvirB promoter. virD4Ap was PCR amplified from pBT-virD4 [46] using the primers 5’AGTCGTCATATGCATAGTTCCAATCAT-3’ and 5’TTAGTGCTCGAGCTACTTTAGTCTTCC-3’. The PCR product was digested with NdeI and
XhoI and ligated to similarly digested ColE1 plasmid, pPC914KS+ [44]. Plasmid pTB12
expresses the W. pipientis virD4 homolog (virD4Wp) from the PvirB promoter. virD4Wp was
PCR amplified using pCR-VirD4 as a template (provided by Katrin Gentil; Bonn, Germany)
and primers 5’-TAAGCGATCACCATGGGTCATAGC-3’ and 5’GCTAGCTCGGGTACCTTACTTTCC-3’. The PCR product was digested with NcoI and
KpnI, and the resulting fragment was ligated into similarly digested pPC914KS+. Plasmid
pTB26 expresses the pKM101 virD4 ortholog (traJ) from the PBAD promoter. traJ was PCR
amplified using pKM101 as a template and primers 5’CAGTAGCCATGGACGATAGAGAAAGA-3’ and 5’ACAATTGGTACCTCAGATCTCCCTCAG-3’. The PCR product was digested with NcoI and
KpnI, and the resulting fragment was ligated into similarly digested pBAD24-Kanr. Plasmid
pTB37 expresses virD4AtΔ553, which encodes A. tumefaciens VirD4 deleted of its Cterminal 104 residues, from the PvirB promoter. virD4AtΔ553 was PCR amplified using
plasmid pKA9 [45] as a template and primers 5’-CGGTGAACATATGAATTCCAGCAA-3’
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and 5’-CTATTAGGTACCTCAGGGCTCAGGCAGAGA-3’. The PCR product was digested
with NdeI and KpnI, and the resulting fragment was ligated into similarly digested pXZ27
[39], replacing the virE2 gene. Plasmid pTB49 expresses the R. rickettsii virD4 homolog
(virD4Rr) from the PBAD promoter. virD4Rr was PCR amplified from genomic DNA sent from
the Betsy Kleba lab using the primers 5’-GTGCCATGGCATAAGATACTTAAAG-3’ and 5’ATTCTCGAGTTACTCATTATTTTCCGG-3’. The PCR product was digested with NcoI and
XhoI, and the resulting fragment was ligated into pBAD24 digested with NcoI and SalI. All
plasmid constructs were confirmed by PCR, digestion analysis, and sequencing.
A postdoctoral fellow in the Christie lab, Dr. N. Whitaker, created the following
plasmid constructs. Plasmid pNW5 expresses virD4At from the Plac promoter. virD4At was
PCR amplified using plasmid pKA9 as a template and primers 5’CGGTGAACATATGAATTCCAGCAA-3’ and 5’GTTCTCGAGTCATTTCGCAGGCTGTGCCG-3’ (Table 2.2). The PCR product was
digested with NdeI and XhoI and the resulting fragment was ligated into similarly digested
pBSIIKS+NdeI [37]. Plasmid pNW7 expresses traJΔAAD from the PBAD promoter. The AAD
of TraJ (amino acids 186-298) was deleted using overlapping PCR [47, 48]. The gene
sequences encoding residues 1-185 and 299-509 of traJ were PCR amplified using the
primers 5’-CCATGGACGATAGAGAAAGAGGC-3’ and 5’GCAGGGAAAAATTTTCAGTGCGTTTATCATAGG-3’, and 5’TGATAAACGCACTGAAAATTTTCCTGCGTGACTGGC-3’ and 5’GGTACCTCAGATCTCCCTCAGTTCAA-3’, respectively. The two PCR products were used
as templates for overlapping PCR with outside primers (5’CCATGGACGATAGAGAAAGAGGC-3’ and 5’-GGTACCTCAGATCTCCCTCAGTTCAA-3’).
The final PCR product was digested with NcoI and KpnI, and the resulting fragment was
ligated into similarly digested pBAD24. Plasmids were confirmed with sequencing
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Table 2.2 Oligonucleotides used for T4CP and effector constructions
VirD4 Homologs
VirD4Ap

5’-AGTCGTCATATG1CATAGTTCCAATCAT-3’
5’-TTAGTGCTCGAG2CTACTTTAGTCTTCC-3’

VirD4Wp

5’-TAAGCGATCACCATGG3GTCATAGC-3’
5’-GCTAGCTCGGGTACC4TTACTTTCC-3’

VirD4Rr

5’-GTGCCATGG3CATAAGATACTTAAAG-3’
5’-ATTCTCGAG2TTACTCATTATTTTCCGG-3’

VirD4AtΔ553

5’-CGGTGAACATATG1AATTCCAGCAA-3’
5’-CTATTAGGTACC4TCAGGGCTCAGGCAGAGA-3’

VirD4ApΔ574 Reverse
VirD4At Reverse (pNW5)
TraJ

5’-AGTTCTCGAG2CTACTTTTCAGGATCGTACGG-3’
5’-GTTCTCGAG2TCATTTCGCAGGCTGTGCCG-3’
5’-CAGTAGCCATGG3ACGATAGAGAAAGA-3’
5’-ACAATTGGTACC4TCAGATCTCCCTCAG-3’

TraJΔAAD (1-185)

5’-CCATGG3ACGATAGAGAAAGAGGC-3’
5’-GCAGGGAAAAATTTTCAGTGCGTTTATCATAGG-3’

TraJΔAAD (299-509)

5’-TGATAAACGCACTGAAAATTTTCCTGCGTGACTGGC-3’
5’-GGTACC4TCAGATCTCCCTCAGTTCAA-3’

Chimeric VirD4’s
TraJ::VirD4ApΔ574*

5’-TTCCGGGTCATAAGGTTCTTGG-3’
5’-TAAATTCGTGGTGGTGTTGAAGG-3’

TraJ::VirD4Wp**

5’-GATTATTCTTTCTCTATAAATGATAAAAGCGATCAGACCG
CCAAC-3’
5’-GCTTTTATCATTTATAGAGAAAGAATAATCGAGTGGCGG
CC-3’
5’-GTATCTCGAG2TTACTTTCCATTACTTTTTGGTTTATCACC
ATCATCTTCATC-3’

TraJ::VirD4WpΔ574**

5’-CTATCTCGAG2TTATGGGTCATATGGCTCCTGTGTAGGT
ACATAAGTC-3’

TraJ TMD (1-75)

5’-CATACCATGG3ACGATAGAGAAAGAGGCTTAGCATTTTT
ATTTG-3’
5’-GTATCTCGAG2TATATATCATATG1ATAAATGATAAAAGCG
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ATCAGACCGCCAAC-3’
VirD4At SDΔ553

5’- CATATATATACATATG1AATCAGAAGCATCACGGGACGG-3’
5’- GTTCTCGAG2TCAAGGGTGCGGGCTCAGGCAG-3’

TraJ::VirD4At (1-190)

5’-TCATGA6ATGGACGATAGAGAAAGAGG-3’
5’-GAAAAACACCCAGCCAGAATCTAGGGGGGAAAACTTGA
AAAC-3’

TraJ AAD (186-298)

5’-TCCCCCCTAGATTCTGGCTGGGTGTTTTTCAATGAAA-3’
5’-AATGCAGGTCTTCTTACCTTCCGGCATTTTCAAATGTG-3’

VirD4At (347-656)

5’-AAAATGCCGGAAGGTAAGAAGACCTGCATTTATCTTTGT
GTCAGTC-3’
5’-CTCGAG2TCATTTCGCAGGCTGGTGCCGGTGC-3’

TraJ (1-185)***
VirD4At AAD (132-346)

5’- ATGAGTCTTCCGCTCTTCAGTGCGTTTATCATAGGCG-3’
5’-GATAAACGCACTGAAGAGCGGAAGACTCATTGTTACAA
TCC-3’
5’- CACGCAGGGAAAAATTCCTCCGGAGATCGTAAACGGAA-3’

TraJ (299-509)***

5’- TTACGATCTCCGGAGGAATTTTTCCCTGCGTGACTGGC
TT-3’

Effector genes
Ats-1

5’-GTGCTCCATATG1CTAATAAGAAGAATTCTG-3’
5’-GTAATTGGTACC4CTCGAG2TTACCTCGTACCTTTACC-3’

Ats-1 CTD Forward
Aph_0111

5’-GTACTTCATATG1GAACGCATTTTCTCATTG-3’
5’-GGACTGCATATG1TCAATCGATTGT-3’
5’-TTGCGCCTCGAG2CTATCCAGATATAG-3’

WD0636

5’-GCCGAGCATATG1AGTAAAAAAGAAAAAGAG-3’
5’-CACGGTACC4TCATAATTTCTCAAATAACTTTTC

WD0811

5’-GTCCATATG1ATGATATCCAATAATTCT-3’
5’-GATGGTACC4TCAATTCATTTGTAA-3’

WD0830

5’-TCGTAGCATATG1AAACAAGGAGATAAG-3’
5’-GTAGGTACC4TTACACTGTTCCTGGAGT

VirE3

5’-GATGCATATG1GTGAGCACTACGAAG
5’-GATCGGTACC4TTAGAAACCTCTGGAGG

VirF

5’-GCACCATATG1AGAAATTCGAGTTTGCG
5’-GATATTGGTACC4TCATAGACCGCGCGTTG
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Other primers
Cre

5’-GATAGAGCTC5AGGAGGTATTCACCATGTCCAATTTACT
GACCGTACACCAAAATTTGC-3’
5’-CATGGTACC4TATATATCATATG1ATCGCCATCTTCCAGC
AGGC-3’

TraJ deletion

5’-CTGGGAACCAAAAAAGGAGCGCTGACCATGG3GTTGGG
TAACGCCAGGGTTTTCC-3’
5’-TGGCGGGTAATCGTGGTTATATCAACCATGG3CACACAG
GAAACAGCTATGACCATGATTAC-3’

Underlined restriction sites are as follows: 1NdeI (CATATG), 2XhoI (CTCGAG), 3NcoI
(CCATGG), 4KpnI (GGTACC), 5SacI (GAGCTC), 6BspHI (TCATGA)
*TraJ::VirD4ApΔC was constructed via inverse PCR by insertion of a stop codon.
**Chimeras TraJ::VirD4Wp and TraJ::VirD4WpΔ574 were constructed by overlapping PCR
using the TraJ forward primer. Internal and reverse primers are specified.
***The TraJ+VirD4AtAAD chimera was constructed using the same forward primer as TraJ
TMD and the same reverse primer as TraJ.
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Construction of virD4 deletion strains and chimeric virD4 plasmids
The virD4 null strain Mx355 contains an IncP plasmid, pPH1JI [27, 49], which
encodes resistance to gentamicin, chloramphenicol, spectinomycin, and streptomycin.
Mx355 was cured of pPH1JI as follows. ColE1 plasmids containing VirD4 homologs behind
a PVirB promoter (Table 2.1) were ligated to another IncP plasmid, pXZ151 [39]. The
resulting co-integrates were introduced to Mx355 cells by electroporation [50] and
transformants were plated on high concentrations of kanamycin (300 µl/ml). Colonies were
consecutively streaked for isolation on kanamycin plates for two overnight growth cycles,
after which colonies were patched on gentamicin (100 µg/ml) to test for sensitivity as an
indicator of pPH1JI curing.
A traJ deletion in pKM101-Spcr (Table 2.1) was obtained by recombineering [51-53].
pKM101-Spcr was conjugatively transferred into E. coli strain HME45 [51, 53], which
contains a defective λ prophage that can be temperature induced to activate Red
recombination. In this system, the λ Red subunits Exo and Beta use single strand annealing
to generate recombinants. The Exo subunit is a 5’-3’ exonuclease that is thought to bind the
end of a dsDNA fragment during replication, while the Beta subunit is a ssDNA binding
protein that promotes annealing between complementary ssDNA. Briefly, upon degradation
of dsDNA by Exo, Beta binds 3’ ssDNA overhangs. Introduction of the complementary
sequence (e.g. PCR product) allows Beta to anneal the two complementary stands to
generate recombinants.
A linear DNA fragment containing a cassette conferring Kanr from the plasmid
pUC4K, flanked by NcoI restriction sites, was PCR amplified using primers 5’CTGGGAACCAAAAAAGGAGCGCTGACCATGGGTTGGGTAACGCCAGGGTTTTCC-3’
and 5’TGGCGGGTAATCGTGGTTATATCAACCATGGCACACAGGAAACAGCTATGACCATGATT
AC-3’, bearing 25 bp of sequence homology to the regions upstream and downstream from
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traJ, respectively (Table 2.2). The purified PCR product was electroporated into HME45
cells containing pKM101-Spcr after temperature induction and Kanr recombinants were
selected. pKM101-Spcr is a multicopy plasmid, and recombination does not occur on all
copies within a single cell. Therefore, it was necessary to isolate a strain carrying only the
traJ-deleted plasmid. For this, Kanr colonies were sequentially grown in LB broth containing
kanamycin (200 µg/ml) for 4 days prior to plating for isolated colonies on LB plates
containing kanamycin (200 µg/ml). The kanr cassette was deleted by NcoI digestion and religation of the pKM101-Spcr plasmid. The traJ deletion was confirmed by absence of a PCR
product corresponding to traJ using primers 5’-CAGTAGCCATGGACGATAGAGAAAGA-3’
and 5’-ACAATTGGTACCTCAGATCTCCCTCAG-3’ (Table 2.2).
Plasmids pTB51 and pTB52 express the traJ::virD4Wp and traJ::virD4WpΔ574
chimeric T4CP’s, respectively, from the PBAD promoter. These plasmids were created by
overlapping PCR [47, 48] with the gene fragments corresponding to the TraJ TMD and the
respective SD fragments of VirD4Wp. PCR products were digested with NcoI and KpnI, and
the resulting fragments were ligated into similarly digested pBAD24 [42] or pBAD24-Kanr.
Plasmid pTB38 encodes traJ::virD4Ap within the vector plasmid pMK-RQ; the traJ::virD4Ap
gene fragment was synthesized and codon optimized for use in E. coli by Invitrogen.
Plasmid pTB39 expresses traJ::virD4Ap from the PBAD promoter. The traJ::virD4Ap gene
fragment was obtained as an NcoI/KpnI fragment from pTB38, and inserted into similarly
digested pBAD24. Plasmid pTB50 expresses traJ::virD4ApΔ574 which encodes the
TraJ::VirD4 chimeric T4CP deleted of C-terminal residues 574-740. This plasmid was
generated by inserting a stop codon at codon 574 of pTB39 by inverse PCR with primers 5’TTCCGGGTCATAAGGTTCTTGG-3’ and 5’-TAAATTCGTGGTGGTGTTGAAGG-3’ (Table
2.2).
Plasmid pNW1 expresses coding sequence for the TraJ TMD from the Plac promoter.
It was constructed by Dr. N. Whitaker by amplification of coding sequence for the TraJ TMD
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from a pKM101 template using primers 5’CATACCATGGACGATAGAGAAAGAGGCTTAGCATTTTTATTTG-3’ and 5’GTATCTCGAGTATATATCATATGATAAATGATAAAAGCGATCAGACCGCCAAC-3’ (Table
2.2). The PCR product was digested with NcoI and XhoI, and the resulting fragment was
ligated into similarly digested pBSIIKS+ [32]. Plasmid pNW2 expresses the traJ::virD4At
chimeric T4CP from the Plac promoter. It was constructed by inserting coding sequence for
the SD of VirD4At, obtained as an NdeI/XhoI fragment from pKA38 [45], into similarly
digested pNW1. Plasmid pNW4 expresses traJ::virD4AtΔ553 from the Plac promoter. The
sequence encoding the VirD4At SD without residues 553-656 was PCR amplified using
pKA38 as a template and primers 5’CATATATATACATATGAATCAGAAGCATCACGGGACGG-3’ and 5’GTTCTCGAGTCAAGGGTGCGGGCTCAGGCAG-3’ (Table 2.2). The PCR product was
digested with NdeI and XhoI and the resulting fragment was ligated to similarly digested
pNW1. Plasmid pNW6 expresses traJ::virD4AtΔAAD from the Plac promoter. The sequence
encoding the VirD4At SDΔAAD, obtained as an NdeI/XhoI fragment from plasmid pCM39,
was inserted into similarly digested pNW1.
Plasmid pNW10 expresses traJ::virD4At with AADtraJ from the Plac promoter. The
sequences encoding amino acids 1-190 of the TraJ::VirD4At chimera expressed by pNW2,
the AAD domain of TraJ (amino acids 186-298), and amino acids 347-656 of VirD4At were
PCR amplified using primers 5’-TCATGAATGGACGATAGAGAAAGAGG-3’ and 5’GAAAAACACCCAGCCAGAATCTAGGGGGGAAAACTTGAAAAC-3’, 5’TCCCCCCTAGATTCTGGCTGGGTGTTTTTCAATGAAA-3’ and 5’AATGCAGGTCTTCTTACCTTCCGGCATTTTCAAATGTG-3’, and 5’AAAATGCCGGAAGGTAAGAAGACCTGCATTTATCTTTGTGTCAGTC-3’ and 5’CTCGAGTCATTTCGCAGGCTGGTGCCGGTGC-3’ (Table 2.2). Overlapping PCR was
used to amplify the three PCR products together as a single product with outside primers
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from the first and third reactions. The final PCR product was digested with BspHI and XhoI
and the resulting fragment was ligated into similarly digested pBSIIKS+. Plasmid pNW11,
expresses traJ with AADvirD4At from the PBAD promoter. The sequences encoding TraJ amino
acids 1-185, VirD4At AAD (amino acids 132-346), and the amino acids 299-509 of TraJ were
PCR amplified using primers 5’-CATACCATGGACGATAGAGAAAGAGGCTTAGCATTTTT
ATTTG-3’ and 5’- ATGAGTCTTCCGCTCTTCAGTGCGTTTATCATAGGCG-3’, 5’GATAAACGCACTGAAGAGCGGAAGACTCATTGTTACAATCC-3’ and 5’CACGCAGGGAAAAATTCCTCCGGAGATCGTAAACGGAA-3’, and 5’TTACGATCTCCGGAGGAATTTTTCCCTGCGTGACTGGCTT-3’ and 5’ACAATTGGTACCTCAGATCTCCCTCAG-3’ (Table 2.2). Overlapping PCR was used to
amplify the three PCR products together as a single product with outside primers from the
first and third reactions. The final PCR product was digested with NcoI and KpnI and the
resulting fragment was ligated into similarly digested pBAD24. All chimeric constructs were
verified by sequencing.

Construction of Cre fusion plasmids
The plasmid pBAD33-Cre was prepared by PCR amplification of the cre insert, using
pZD96 as a template and the primers 5’GATAGAGCTCAGGAGGTATTCACCATGTCCAATTTACTGACCGTACACCAAAATTTGC3’ and 5’-CATGGTACCTATATATCATATGATCGCCATCTTCCAGCAGGC-3’ (Table 2.2).
PCR products incorporated a SacI site followed by the Shine-Dalgarno sequence (AGG
AGG) at the 5’ end and NdeI and KpnI sites at the 3’ end. The two restriction sites at the 3’
end allows for the creation of Cre-effector fusion proteins. The PCR product was digested
with SacI/KpnI and the resulting fragment was ligated to similarly digested pBAD33 [42].
Known or putative effector genes were PCR amplified or isolated as described in Table 2.1.
The DNA fragments were digested with NdeI/KpnI or NdeI/XhoI, and the resulting fragments
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were ligated to similarly digested pBAD33-Cre to create translational fusions. All constructs
were verified by restriction digestion analysis and sequencing.

Protein analysis by western blot
To assay for the accumulation of Cre-effector fusion proteins, arabinose induced
cells were harvested at mid-log phase and normalized to equivalent optical densities
(OD600), re-suspended in Laemmli’s buffer (50 mM Tris-HCl, 4% SDS, 20% glycerol, 20 mM
dithiothreitol, 1% β-mercapatoethanol, 0.1% bromophenol blue, pH 6.8), and boiled for 10
minutes. The boiled cell lysates were resolved by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) as previously described [54], with modifications. Proteins
were transferred to polyvinylidene fluoride (PVDF) membranes and incubated with anti-Cre
antibodies (Novus Biologicals) overnight. Western blots were developed with goat antimouse antibodies conjugated to horseradish peroxidase (HRP; New England Biolabs), and
visualized by chemiluminescence (Thermo Scientific).

Conjugation assays
A. tumefaciens and E. coli donor strains were assayed for conjugative DNA transfer
through the VirB/VirD4 and pKM101-encoded T4SSs as follows [33, 36, 55]. The
promiscuous, mobilizable IncQ plasmid pML122ΔKm [40, 55] served as a DNA substrate.
For A. tumefaciens conjugative matings, pML122ΔKm was introduced by electroporation
[56] together with the ColE1/pXZ151 co-integrates described above into wild-type strain
A348 or the Mx355 (virD4-) mutant. These strains functioned as donors with A348-Spcr as a
recipient in mating experiments [36, 40]. Conjugative matings were carried out as
previously described [55]. Briefly, A. tumefaciens strains were induced 16-18 hours at room
temperature, as described above. Cells were mixed in a 1:5 ratio of donors to recipients
and spotted onto sterile nitrocellulose filters placed on ABIM agar plates. Suspensions of

	
  

28	
  

	
  
donors only and recipient only were also spotted onto filters to serve as controls. Plates
were incubated for 4-5 days at 18 °C. Cells were re-suspended in 1x PBS and serial
dilutions were prepared. Dilutions were spread on antibiotic containing MG/L plates
selecting for donors, recipient, and transconjugants. Frequency of transfer was calculated
as the number of transconjugants per donor cell. Mating experiments were carried out at
least three times in duplicate, and results are reported as mean frequency of transfer with
standard deviations indicated.
E. coli conjugation assays were carried out as previously described [57], with strains
DH5α and WM1650 serving as the donor and recipients, respectively. Briefly, strains were
grown overnight with antibiotic selection in LB broth at 37 °C. Cells were then diluted 1:10 in
fresh LB with the addition of 0.2% arabinose or 200 µM IPTG as appropriate for plasmid
induction, and grown at 37 °C for 1 hour. Donors and recipients were mixed in a 1:1 ratio
and centrifuged for 1 min. Cells were re-suspended in 20 µl of the supernatant and spotted
onto sterile filters placed on LB induction plates. Suspensions of donors alone and the
recipient alone were prepared simultaneously as controls. After overnight incubation at 37
°C, cells were re-suspended in 1x PBS and serial dilutions were plated on LB plates
selecting for donors, recipient, and transconjugants. Frequency of transfer was calculated
as the number of transconjugants per donor. All mating experiments were performed at
least three times in duplicate or triplicate, and results are reported as the mean frequency of
transfer with standard deviations indicated.

Virulence assays
A. tumefaciens strains were assayed for T-DNA and effector protein transfer using a
tumor formation assay on Kalanchoe daigremontiana leaves [24, 39]. Wild-type A348 and
avirulent strain Mx355 (virD4-) served as positive and negative controls, respectively.
Briefly, bacterial strains were freshly streaked on MG/L agar plates with the appropriate
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antibiotics and grown at room temperature for 2 days. Plant leaves were wounded by
scratching with a sterile toothpick and immediately inoculated with cells from the 2-day
plates. All strains were inoculated onto at least 5 different leaves and virulence was
assessed after 6-8 weeks.

CRAfT (Cre-recombinase Reporter Assay for Translocation)
The Cre fusion reporter [5] was used to assay for the translocation of known or
putative effector proteins from E. coli MS411 donor cells into the recipient E. coli strain
CHS26Cm::LTL, which contains a loxP-Tetr-loxP cassette interrupting a cat gene on the
bacterial chromosome [33]. Plasmid pBBR1MCS2-Genr was introduced into the recipient
strain for additional antibiotic selection of recombinants. Cre-mediated excision in the
recipient strain results in colonies exhibiting a Camr, Genr, Tets phenotype. This recipient
strain produced higher than desired levels of background growth (i.e. growth on Cre-only
controls). Several experiments were repeated with another recipient generated by plating
100 ml of CHS26Cm::LTL liquid cell culture on LB plates containing 50 µg/ml of rifampicin.
After growing at 37 °C overnight, Rifr colonies were selected and made competent. The
non-mobilizable plasmid pUC4K, encoding resistance to carbenicillin and kanamycin, was
introduced to the Rifr recipient to produce CHS26Cm::LTL,rifr(pUC4K). The latter recipient
genrally confirmed the results observed with the former recipient, while diminishing the
background growth. Results are reported using the original CHS26CM::LTL(pBBR1MCS2Genr) recipient unless otherwise noted.
CRAfT was performed similarly to the conjugation assay described above. Briefly,
strains were grown overnight in LB broth with antibiotic selection at 30 °C. Cells were
diluted 1:10 into fresh LB containing 0.2% arabinose or 200 µM IPTG as appropriate for
plasmid induction, and grown at 30 °C for 1 hour. Cell suspensions were normalized by
OD600. Donor and recipient cells were mixed in a 1:1 ratio and centrifuged for 1 min. Cell
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pellets were re-suspended in 20 µl of the supernatant and spotted onto sterile nitrocellulose
filters on LB induction plates. Concurrently, donors alone and recipient alone were prepared
as controls. Plates were incubated overnight at 30 °C. Cells were re-suspended in 1x PBS
and serially diluted. Donors, recipient, and recombinants were selected for on LB agar
plates containing the appropriate antibiotics. Frequency of recombination was calculated as
the number of recombinants per donor. All CRAfT experiments were performed at least
three times in duplicate, and results are reported as the mean frequency of recombination
with standard deviations.
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Chapter 3. Chimeric T4SS in Agrobacterium and Functional Characterization of the
VirD4At C-terminal Extension
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Introduction
The A. tumefaciens VirB/VirD4 T4SS is comprised of a channel that directs
oncogenic T-DNA and effector proteins across the cell envelope and into plant cells during
infection [6, 58]. Previous studies from our lab have shown that the VirD4 T4CP functions
as a receptor for the DNA and protein substrates of the VirB/VirD4 T4SS [8, 59, 60]. A.
tumefaciens is a member of the Alphaproteobacteria and is closely related phylogenetically
to Rickettsial species (Figure 3.1A). Members of the Rickettsiales are intracellular
pathogens and they also carry virB/virD4-like genes in their genomes (Figure 3.1B).
Therefore, the Rickettsia spp. are postulated to assemble T4SSs resembling the A.
tumefaciens VirB/VirD4 T4SS for the purpose of delivering effector proteins into the
mammalian host during infection. However, studies of Rickettsial pathogens are currently
hampered by the inability to grow these pathogens in laboratory media and also because
they are genetically intractable.
Here, I sought to test whether T4CP’s from three Rickettsial species, A.
phagocytophilum, R. rickettsii Sheila Smith strain, and W. pipientis, could functionally
substitute for the A. tumefaciens VirD4 subunit to mediate translocation of DNA or protein
substrates. The overarching goal was to use A. tumefaciens as a surrogate host and
chimeric T4SSs composed of A. tumefaciens VirB subunits and Rickettsial VirD4 subunits,
first, to gain evidence that the Rickettsial VirD4 subunits are functional, and second, to
identify novel protein substrates that are translocated through Rickettsial VirB/VirD4 T4SSs.
This line of study gains support from previous work showing that substitutions of
VirD4 subunits with closely related homologs enable assembly of functional T4SS’s [9, 61].
Here, to test whether Rickettsial VirD4 homologs could form a chimeric T4SS in A.
tumefaciens, I assayed for the capacity of virD4 genes from A. phagocytophilum (virD4Ap),
R. rickettsii (virD4Rr), and W. pipientis (virD4Wp) to complement the virD4At null mutation.
The initial complementation tests assayed for i) translocation of the T-DNA and protein
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effectors to plant cells using a virulence assay and ii) translocation of the promiscuous,
mobilizable IncQ plasmid to A. tumefaciens recipients. I also assayed for the capacity of
Rickettsial virD4 genes to exert negative dominance when expressed in an otherwise wildtype A. tumefaciens background.
Finally, as discussed earlier, VirD4At and other T4CPs, including those from A.
phagocytophilum and W. pipientis, carry C-terminal extensions compared with T4CPs such
as pKM101-encoded TraJ or the structural prototype for the T4CP family, E. coli TrwBR388.
These CTEs are typically variable with an overall negative charge, and I sought to test
whether the A. tumefaciens VirD4 T4CP requires its CTE for function. I was unable to
demonstrate that the chimeric T4SSs functioned to translocate substrates, however, I
gained genetic evidence for poisoning interactions between the Rickettsial T4CPs and the
A. tumefaciens VirB system. I also demonstrated that VirD4At’s CTE is required for
translocation of T-DNA and the VirE2 effector protein to plant cells, but dispensable for
translocation of the promiscuous IncQ plasmid to Agrobacterial recipients.
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Figure 3.1 Diversity of T4SSs in Alphaproteobacteria
A. Phylogenetic tree indicating the close relationship between A. tumefaciens and
Rickettsial species. This image is modified from Beninati, et al. 2004 to indicate
species presented in this thesis [62]. Permission for use was granted by the
American Society for Microbiology.
B. Comparison of T4SSs between species of the Rickettsiales and other bacterial
species. This image was modified from Gillespie, et al. 2010 to highlight the species
presented in this thesis [17]. Permission for use was granted by the American
Society of Microbiology. At, A. tumefaciens; Ec, E. coli; Rt, Rickettsia sp.; Wp,
Wolbachia pipientis; Ap, A. phagocytophilum.
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Results

Rickettsial VirD4 homologs do not complement a virD4 mutant for substrate transfer
To test the ability of Rickettsial VirD4 homologs to functionally substitute for A.
tumefaciens VirD4, I first cloned the virD4 genes from plasmids obtained from the labs of
Katrin Gentil and Yasuko Rikihisa, as described above. For expression in A. tumefaciens, I
cloned each of the genes downstream of the acetosyringone-inducible virB promoter (PvirB)
on a ColE1 plasmid. I then ligated the ColE1-based virD4 expression plasmids to an IncP
plasmid, which replicates in A. tumefaciens. I introduced the virD4 expression plasmids into
the virD4 mutant strain Mx355 or the wild-type strain A348 to assay for functionality or
negative dominance, respectively. I confirmed the presence of the plasmids and virD4
genes of interest in the different A. tumefaciens strains by PCR amplification with the
primers originally used to clone the genes. It is important to note that much of this work
using the plasmid containing virD4Rr yielded negative results and it was later discovered that
the construct provided to our lab contained a deletion of ~100 bp. This construct, and any
data generated, has been left out of this thesis. Several attempts to generate the correct
construct failed, although I was able to clone virD4Rr behind a PBAD promoter for use in E.
coli as discussed in chapter 4.
I first assayed for the capacity of Mx355 carrying the virD4-expression plasmids to
translocate the A. tumefaciens T-DNA and effector proteins to plants, as monitored by
virulence on Kalanchoe leaves. As shown in Figure 3.2, A. tumefaciens strains A348 (WT)
and Mx355 (ΔvirD4) expressing virD4At incited tumors within 6-8 weeks on plant leaves,
although the latter strain incited tumors that were reproducibly smaller than WT A348. By
contrast, Mx355 expressing the Rickettsial virD4Ap, or virD4Wp genes failed to incite virulence
on plants.
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Both A348 and Mx355 expressing virD4At mobilize the transfer of the nonselftransmissible IncQ plasmid pML122 into agrobacterial recipients. I introduced pML122 into
the above strains to assay for the capacity of the Rickettsial virD4 genes to mobilize IncQ
transfer. As shown in Figure 3.2B, A348 and Mx355 expressing virD4At mobilized IncQ
plasmid transfer at frequencies of ~10-4 transconjugants per donor (Tc’s/D). By contrast,
Mx355 expressing the Rickettsial virD4 genes failed to mobilize transfer of the IncQ plasmid.
Taken together, these findings suggest that the Rickettsial virD4 genes do not functionally
substitute for virD4At for transfer of A. tumefaciens DNA or protein substrates.
Protein levels of the VirD4 homologs could not be assessed at this time, as
antibodies were not available and previous attempts to attach an N- or C-terminal tag to
VirD4At have rendered it non-functional. Polyclonal antibodies against VirD4At were tested
for cross-reactivity with the VirD4 homologs, however detection of the homologs by western
blot was not successful. Therefore, it is unknown if lack of complementation by the
Rickettsial virD4 genes is due to problems in gene expression, instabilities of the
synthesized T4CPs, or the inabilities of the T4CPs to recognize the A. tumefaciens
substrates.
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Figure 3.2 Tests for complementation of the A. tumefaciens ΔvirD4 mutation by virD4
genes from Rickettsial species.
A. T-DNA and effector protein transfer as monitored by virulence on wounded
Kalanchoe leaves. Representative leaf showing tumor induction of wild-type (WT)
strain A348, ΔvirD4 mutant Mx355, and Mx355 expressing virD4At, virD4Ap, or
virD4Wp.
B. DNA substrate transfer frequency and virulence data. Conjugative transfer
frequency of the IncQ plasmid, pML122, is presented as transconjugants per donor
cell (black bars) with standard deviations indicated. Virulence on plant leaves (white
bars), as measured on a scale of three pluses (as incited by the WT strain), two and
one pluses for attenuated virulence, minus sign, avirulent. * IncQ plasmid transfer is
statistically significant when compared to WT (P<0.0001)
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Evidence for expression of virD4 homologs in A. tumefaciens A348
To examine the possibility that the Rickettsial VirD4 T4CPs interact nonproductively
with the A. tumefaciens VirB channel or VirB/VirD4 substrates, I tested whether A348 strains
carrying the virD4 expression plasmids displayed altered substrate transfer as monitored by
plant virulence assays and IncQ plasmid mobilization. As shown in Figure 3.3, A348
carrying a plasmid expressing virD4At displayed a slight reduction in virulence as shown by
slightly smaller tumors than WT A348. A348 carrying the virD4Wp expression plasmid also
showed a slight attenuation in virulence. However, A348 carrying the virD4Ap expression
plasmid was highly attenuated for virulence, consistent with the idea that VirD4Ap somehow
poisons substrate engagement with or transfer through the VirB/VirD4 T4SS.
A348 strains carrying the virD4 expression plasmids were also assayed for
mobilization of the IncQ plasmid pML122. As shown in Figure 3.3, trans-expression of all of
the virD4 homologs including virD4At resulted in a slight reduction of ~1 order of magnitude
in IncQ plasmid transfer compared with WT A348, although this was not a statistically
significant decrease from wild-type transfer. All of the trans-expressed virD4 genes were
from an IncP replicon, whose copy number is estimated at ~5 times that of the Ti plasmid,
which carries the virB and virD4 genes as well as the oncogenic T-DNA and effector genes.
The observed dominant negative effects accompanying trans-expression of the virD4 genes
on virulence and IncQ plasmid transfer could arise from overproduction of the VirD4 T4CPs.
The overproduced T4CPs might interact nonproductively with the VirB machinery, creating
nonfunctional secretion channels, or they might sequester DNA or protein substrates and
prevent their engagement with the native VirB/VirD4 machine.
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Figure 3.3 Tests for dominant negative effects of virD4 genes from Rickettsial
species expressed in wild-type A. tumefaciens strain A348
DNA substrate transfer frequency and virulence data. Conjugative transfer frequency of the
IncQ plasmid, pML122, is presented as transconjugants per donor cell (black bars) with
standard deviations indicated. Virulence on plant leaves (white bars), as measured on a
scale of three pluses (as incited by the WT strain), two and one pluses for attenuated
virulence, minus sign, avirulent. WT, A348; WT strain expressing the virD4 genes indicated.
Expression of virD4 genes in trans did not cause a statistically significant decrease in IncQ
transfer compared to wild-type (P>0.05).
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The C-terminal extension (CTE) of VirD4At is important for virulence but not for IncQ
transfer
The VirD4 family members share generally high sequence conservation among their
nucleotide-binding domains, but are considerably more variable among their TMD’s, AAD’s,
and CTE’s. The TMD’s are implicated in mediating interactions with transfer channels [9],
and their sequence variation could be attributable to an evolved specificity in interaction with
the cognate T4SS channel. The variations in the AAD’s and/or CTE’s however, might be
important for evolved specificity in engagement of effector proteins with cognate T4SS
channels. As mentioned above, AAD’s within the Rickettsial species are quite conserved,
suggesting that if this domain contributes to substrate docking, substrates are likely very
similar between these species.
Sequence analysis of several T4SSs revealed that T4SSs dedicated to translocation
of protein effectors generally possess CTE’s of variable length and amino acid composition;
whereas systems dedicated to conjugative DNA transfer typically lack CTE’s. Among the
Rickettsial homologs in this study, the VirD4 subunits possess variable C-terminal domains
from 21-167 residues that are highly enriched in acidic residues (Figure 1.4), e.g., VirD4Ap
CTE has 47% Glu/Asp residues. In A. tumefaciens, the VirB/VirD4 T4SS functions both in
DNA and protein transfer. In this system, the CTE is 104 residues with 16% being acidic. In
well-characterized E. coli conjugative plasmids, R388 and pKM101, the VirD4 orthologs lack
CTE’s altogether.
Given these findings, I hypothesized that the C-termini of the VirD4 subunits
contribute to substrate specificity either by a) acting as a docking point for effectors prior to
translocation or b) blocking DNA translocation thereby only allowing protein substrates to be
translocated. To test this hypothesis, I created a virD4 allele encoding VirD4AtΔ553, which is
deleted of its CTE, and assayed for functional complementation of a virD4 null mutation. As
shown in Figure 3.4, Mx355 producing full length VirD4At incites formation of plant tumors
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and transfers the IncQ plasmid at WT frequencies, whereas Mx355 producing VirD4AtΔ553
was avirulent on plants but displayed near wild-type levels of IncQ plasmid transfer. These
findings suggest that the CTE is necessary for VirD4 to interact productively with A.
tumefaciens virulence factors, but is dispensable for interaction and translocation of the
promiscuous IncQ plasmid. Further studies of VirD4’s CTE are described in Chapter 5.
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Figure 3.4. Contribution of the C-terminal extension of A. tumefaciens VirD4 to
substrate transfer
DNA substrate transfer frequency and virulence data. Conjugative transfer frequency of the
IncQ plasmid, pML122, is presented as transconjugants per donor cell (black bars) with
standard deviations indicated. Virulence on plant leaves (white bars), as measured on a
scale of three pluses (as incited by the WT strain), two and one pluses for attenuated
virulence, minus sign, avirulent. WT, A348; ΔvirD4 mutant, Mx355; virD4 expressing wildtype virD4 or virD4AtΔ553. * IncQ plasmid transfer is statistically significant when compared
to WT (P<0.0001)
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Discussion

Transfer of effector molecules using VirD4 homologs in the Agrobacterium type IV
secretion system
The use of chimeric and surrogate T4SSs has been established in a variety of
contexts [9, 20, 22, 23]. This study was aimed at determining whether VirD4 homologs
assemble with the A. tumefaciens VirB subunits to form functional chimeric T4SSs. I
expressed virD4 genes from two Rickettsial homologs, A. phagocytophilum and W. pipientis,
in a virD4-mutant background and determined that they were unable to form a functional
chimeric T4SS, at least with respect to the translocation of A. tumefaciens effectors or the
promiscuous IncQ plasmid pML122. This is not entirely surprising, as I was assaying for
translocation of non-cognate substrates, and at this time there is no evidence that Rickettsial
species are capable of interbacterial conjugation or mobilization of IncQ plasmids.
I also expressed the Rickettsial virD4 genes in the A. tumefaciens strain A348 to
genetically test for dominant effects of these genes over virD4At. I determined that transexpression of the wild-type virD4At gene as well as the virD4Ap and virD4Wp genes conferred
negative dominance both with respect to plant tumorigenesis and IncQ plasmid transfer,
although the latter was found not to be statistically significant. To account for negative
consequence of virD4At trans-expression, I propose that synthesis of VirD4 from the higher
copy number IncP replicon compared with the Ti plasmid results in elevated copies of the
T4CP which interferes with assembly of functional VirB/VirD4 T4SSs or binds available
substrates preventing their interaction with functional VirB/VirD4 T4SSs. The finding that
the Rickettsial virD4 genes, in particular virD4Ap, also exerted negative dominance, suggests
first that the Rickettsial T4CPs are synthesized and second that they similarly ‘poison’
substrate transfer through the VirB/VirD4 T4SS.
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At this time, it is not known how the trans-expressed virD4 genes negatively affect
substrate transfer through the VirB/VirD4 T4SS. It is possible that expression of the
Rickettsial virD4 genes from a single copy plasmid or integration into the Ti plasmid would
enable functional complementation of the virD4At- mutation with respect to translocation of
the A. tumefaciens effectors or IncQ plasmids. It is also possible that the Rickettsial VirD4
T4CPs in fact do interact productively with the A. tumefaciens VirB channel subunits, but
only for translocation of Rickettsial substrates. Although this remains to be tested, such
studies using A. tumefaciens as a surrogate host are complicated because of the difficulty of
genetic manipulation of this bacterium compared to other commonly used model bacterial
species such as E. coli. In Chapter 5, I present results of my studies using E. coli as a
surrogate host in which I demonstrate functionality of chimeric VirD4 T4CPs composed of a
TMD from an E. coli plasmid-encoded T4CP and SDs from A. tumefaciens or Rickettsial
T4CPs. These studies demonstrate a proof-of-principle for the use of chimeric T4CPs, and
warrant future investigations testing whether native or chimeric Rickettsial T4CPs can
mediate translocation of Rickettsial substrates through the A. tumefaciens VirB channel.

The CTE of VirD4At is required for translocation of some, but not all, substrates
There is already experimental support for the idea that T4CP CTEs contribute to
substrate engagement. In the E. coli F-plasmid transfer system, the TraD T4CP carries a
CTE and this CTE has been shown to bind the TraM accessory factor [12]. TraM is an
essential component, along with the TraI relaxase, of the relaxosome that assembles at the
F-plasmid origin-of-transfer (oriT) sequence. Consequently, the TraD CTE-TraM interaction
serves to physically couple the relaxosome with the transfer channel prior to plasmid
transfer. In addition, although the F-plasmid transfer system mobilizes promiscuous IncQ
plasmids, it does so only at very low frequencies of <10-6 Tc’s/D, whereas this T4SS
transfers the F-plasmid at high frequencies exceeding 101 Tc/D. Deletion of TraD’s CTE,
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however, reverses this pattern, so that the T4SS instead translocates the F-plasmid at low
frequencies and the IncQ plasmids at comparatively high frequencies. Therefore, TraD’s
CTE confers substrate specific docking of the F-plasmid substrate and blocks IncQ plasmid
transfer.
In this study, phenotypic analysis of the VirD4AtΔ553 derivative deleted of the CTE
confirmed the importance of the CTE for translocation of A. tumefaciens substrates required
for plant virulence. Yet, this construct supported IncQ plasmid transfer to recipient
agrobacteria at near wild-type levels, indicating that the CTE is not required for recruitment
or translocation of the IncQ plasmid. These findings support a general model in which the
promiscuous IncQ plasmids have evolved to interact with domains or motifs that are
conserved among members of the T4CP superfamily, e.g., possibly the NBD or AAD,
whereas the CTE contributes to engagement of substrates that are dedicated for
translocation through a given T4SS. In Chapter 6, I further analyze the effect of deleting
VirD4’s CTE on DNA and protein transfer using an E. coli chimeric T4SS, and results further
support the idea that the CTE functions as a substrate specificity domain.
After completing these studies with A. tumefaciens as a surrogate host, I determined
that the best strategy for increased translocation efficiency would be to assay for
translocation of native substrates for each of the different VirD4 homologs. Additionally, I
wanted to develop a surrogate host system that was more amenable to genetic
manipulation, and a system in which substrate transfer could be assessed more rapidly and
quantitatively than with the A. tumefaciens virulence assay. It is also noteworthy that in A.
tumefaciens, mobilization of IncQ plasmids through the VirB/VirD4 system occurs at low
frequencies (e.g., the frequency of IncQ plasmid transfer is 10-4 Tc’s/D after a five-day
mating). By contrast, E. coli conjugation systems such as the pKM101-encoded system
which bears strong overall similarity to the A. tumefaciens VirB/VirD4 system, transfers IncQ
plasmids and other plasmid substrates at considerably higher frequencies in 1 - 2 hour
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matings. For these reasons, I focused the remainder of my studies on development of E.
coli as a surrogate host to characterize the functionality of chimeric T4SSs and monitor
translocation of heterologous T4SS effector proteins.
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Chapter 4. The Type IV Secretion System of Escherichia coli pKM101 and Related
Chimeric Systems Mediate Translocation of Heterologous Protein Substrates
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Introduction
The broad-host range conjugative IncN plasmid pKM101, a derivative of R46, has
been studied extensively as an efficient and easily manipulated T4SS [43]. This plasmid
conjugatively transfers from E. coli donors to recipients in 1 h filter matings at efficiencies
≥10-1 transconjugants per donor (Tc’s/D) [43]. By contrast, the A. tumefaciens VirB/VirD4
system delivers IncQ plasmid substrates to agrobacterial recipients at frequencies of 10-410-5 Tc’s/D in 4-5 day filter matings (Figure 3.2). The highly efficient pKM101 transfer
system, coupled with the ease of genetic manipulation of E. coli, makes this an ideal system
for detailed mechanistic studies of type IV secretion in Gram-negative bacteria.
Transposon mutational analyses in the 1980’s identified the regions of pKM101
required for conjugative DNA transfer [43, 63]. More recently, the plasmid was sequenced,
enabling precise definition of the transfer (tra) genes and their putative functions [64]. One
tra gene cluster, closely resembling the A. tumefaciens virB genes both in composition and
gene order, codes for the transfer channel. The second cluster, resembling the A.
tumefaciens virD operon, codes for the TraJ T4CP and the Dtr processing factors.
While the pKM101 T4SS efficiently transfers pKM101 and IncQ plasmid substrates to
E. coli recipient cells, no studies have yet examined whether this system also translocates
protein substrates. Here, I tested whether the native pKM101 system mediates transfer of
known protein substrates of the A. tumefaciens VirB/VirD4 T4SS as well as known or
putative substrates of Rickettsial VirB T4SSs. The A. tumefaciens substrates included three
well-characterized effectors, VirE2, VirE3, and VirF, which are delivered to plant cells during
the course of infection. The Rickettsial substrates included A. phagocytophilum Ats-1, which
is translocated into mammalian cells during infection, and several other proteins whose
T4SS-mediated translocation has been postulated on the basis of sequence composition or
phenotypes detected from production of the Rickettsial proteins in yeast.
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A second goal of these studies was to test whether chimeric systems derived from
the pKM101 T4SS function to mediate transfer of DNA or protein substrates. Specifically, I
substituted the T4CPs from A. tumefaciens or Rickettsial T4SSs for pKM101-encoded TraJ
and tested whether the resulting chimeric systems would translocate the IncQ plasmid or the
respective A. tumefaciens or Rickettsial protein substrates. Earlier studies established a
precedent for the functionality of chimeric T4SSs composed of a T4CP from one system and
the channel subunits from a second [23, 61]. For example, substitution of the R388 T4CP
TrwB, with TraG from plasmid RP4, was shown to restore mobilization of RSF1010 by a
mutant of R388 defective for substrate transfer [23]. It is noteworthy that each of these
chimeric systems was assayed only for their capacity to translocate DNA substrates. My
studies were the first to test whether chimeric conjugation machines are capable of
translocating protein substrates.

Results

The pKM101 conjugative T4SS transfers non-cognate proteins
I assayed for the capacity of the pKM101 T4SS to translocate heterologous protein
substrates with the Cre recombinase Reporter Assay for Translocation (CRAfT). This assay
has been used previously to demonstrate effector protein translocation through the A.
tumefaciens VirB/VirD4 T4SS to yeast or plant cells, and the Legionella pneumophila
Dot/Icm T4SS to other bacterial cells [33, 65, 66]. As shown in Figure 4.1, I expressed
genes encoding the Cre-effector fusions from an arabinose inducible PBAD promoter in E.coli
donor strain MS411. The recipient, CSH26Cm::LTL (pBBR1MCS2-Genr), contains the cat
gene, interrupted by a tetr gene that is flanked by loxP sites. Upon translocation of the Creeffector fusion protein into the recipient cell, Cre recombination at the loxP sites excises the
tetr gene, resulting in a Camr, Tets phenotype. In these studies, recombinants were routinely
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tested for Tets by patching the colonies onto an LB plate containing 20 µg/ml of tetracycline.
On numerous occasions, colonies displayed a partial TetS phenotype where individual
colonies would arise within the patch, as opposed to solid growth of the patch, which would
indicate Tetr. We postulate that this partial sensitivity is due to Cre-mediated recombination
occurring during a point in cell division where two alleles are present within the cell and only
one allele is recombined.
Donor cells expressed genes for the Cre-effector fusion from pBAD33, which is also
Camr. Therefore, to discriminate recipients in which the lox cassette had been excised from
donor cells, it was necessary to introduce additional resistance markers into the recipient.
Initially, I used the broad-host range vector, pBBR1MCS2-Genr, in the recipient and selected
for Cre-effector protein transfer by plating the mating mix on chloramphenicol and
gentamicin. However, this approach proved problematic for the following reason. In these
matings, donor cells potentially translocate not only the Cre-effector protein, but also
pKM101 at high efficiencies, to recipient cells. Once in the recipient cell, pKM101
elaborates a T4SS, which I found to be capable of mobilizing the transfer of pBBR1MCS2Genr back into donor cells, thus enabling donor cells to grow on Cam- and Gen-containing
plates.
pBBR1MCS2-Genr has a mobilization region from an IncP plasmid and no studies to
date have shown that pKM101 is capable of recognizing and translocating a mobile element
with an IncP origin-of-transfer [67, 68]. This discovery, while interesting, necessitated
introduction of alternative resistance markers into the recipient strain for selection of lox
cassette excisants. A suitable recipient was generated through selection of a rifampin
resistant (Rifr) recipient by plating dense cell cultures on LB plates containing rifampicin
followed by introduction of the non-mobilizable plasmid pUC4K, which codes for resistance
to carbenicillin and kanamycin. The Kanr/Crbr/Rifr strains were tested for their capacity to
function as recipients for uptake of pKM101-Spcr as well pML122. While the use of the Rifr
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recipient did not change the overall conclusions drawn from the experiments, it did provide
less background and therefore cleaner data.
I constructed plasmids expressing genes for the Cre-effector fusion proteins from the
PBAD promoter, and a plasmid encoding Cre alone as a control. As mentioned above, I
tested for Cre translocation mediated by effectors from A. tumefaciens (VirE2, VirE3, VirF)
and A. phagocytophilum (Ats-1, Ats-1 CTD – the C-terminal 100 residues of Ats-1that
presumptively carries the C-terminal signal sequence). Transfer of the A. tumefaciens
effectors has been shown by CRAfT [5, 65], and Ats-1 was initially identified as a VirD4Ap
binding partner with a bacterial two-hybrid system and subsequently identified in the
cytoplasms of infected mammalian cells [46]. I tested for the ability of the C-terminus of Ats1 to mediate Cre translocation because it bears features such as clusters of basic amino
acids and a net positive charge identified among translocation signals carried by the A.
tumefaciens T4SS effectors [46]. Additionally, I tested for Cre translocation by fusion to A.
phagocytophilum Aph_0111. Aph_0111 is a putative substrate provided by our collaborator,
Dr. Jason Carlyon, and is annotated as an uridylate kinase (personal communication). I
also assayed for translocation of several Wolbachia putative effectors provided by a second
collaborator, Dr. Irene Newton (personal communication). These effectors were identified in
a high-throughput screen for proteins that induce phenotypic changes such as cell death or
morphological changes when produced in yeast cells. The candidate effectors include the
ankyrin repeat containing protein, WD0636, and two annotated hypothetical proteins
WD0811 and WD0830.
I first tested for production of the Cre-effector proteins in E. coli donor cells. Cells
were induced for synthesis of the Cre-effector proteins as described in the Materials and
Methods, and total cellular proteins were analyzed for accumulation of the fusion proteins by
SDS-PAGE, western transfer, and development of the immunoblots with commercially
available anti-Cre antibodies (Novus Biologicals). As shown in Figure 4.2, most of the
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fusion proteins were detected in the cell lysates, with the exception of WD0830. Several of
the fusion proteins migrated aberrantly in protein gels, as judged from their predicted
molecular sizes. This could be due to intrinsically stable folds or extended structures that
impeded mobility of the fusion protein through the polyacrylamide gels. Regardless, by
immunostaining, I gained evidence that most of the Cre-effector fusions accumulated to
detectable levels upon arabinose induction of the E. coli host cells.
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Donor

pKM101
Spcr

Camr

Recipient

Cre-x

Bacterial
chromosome

Genr

pBAD33Cre-X
(effector)

pBBR1MCS2

loxP
cat
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Figure 4.1 Interbacterial protein translocation by the pKM101 T4SS
The Cre-Recombinase Assay for Translocation (CRAfT) was used to monitor interbacterial
protein transfer. Translocation of the Cre-effector fusion protein, from a donor bacterial cell
containing the pKM101 encoded T4SS is measured by excision of a gene conferring
tetracycline resistance (Tetr) and a transcriptional terminator (term) that is flanked by loxP
sites on the chromosome of E. coli recipient strain CSH26Cm::LTL. Bacteria harboring the
intact reporter are Tetr and Cams. Cre-mediated recombination at the loxP sites allows full
read-through of the cat gene, resulting in a Tets, Camr phenotype. Plasmids shown are
pKM101, pBAD33-Cre-X, where X is a translocated effector protein; and pBBR1MSC2-Genr
(included in the recipient to aid in selection of recombinants
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Figure 4.2 Detection of Cre-effector fusion proteins in E. coli cells
Western blot analysis of Cre-effector fusion proteins produced in E. coli donor cells without
and with induction using 0.2% arabinose were detected by immunostaining of blots with antiCre antibodies and anti-HRP secondary antibodies as described in the Materials and
Methods. Putative fusion proteins are shown by white arrows and Cre is indicated by a
black arrow.
A. Detection of Cre only and Cre fused to the A. tumefaciens effector proteins shown.
B. Detection of Cre fused to the putative A. phagocytophilum effectors indicated. CTD,
Cre fused to the C-terminal domain (CTD) of Ats-1 comprised of the last 100
residues; the gene encoding the putative Aph_0111 effector was provided by Jason
Carlyon.
C. Detection of Cre fused to putative Wolbachia effector proteins; the WD effector
genes were provided by Irene Newton.
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Interestingly, all of the tested Cre-effector fusion proteins were translocated to
recipient cells at detectable frequencies, as monitored by CRAfT (Figure 4.3). Effectors Ats1 CTD and Aph_0111 transferred below the threshold with the original recipient (Figure
4.3A), but transferred into the Rifr recipient above the Cre-alone control at statistically
significant levels (Figure 4.3B). This further emphasizes the superiority of the Rifr recipient
in accurately distinguishing genuine effector translocation. Translocation required arabinose
induction of the Cre-effector proteins and, furthermore, the donor strains and the recipient
strain failed to form colonies on plates selective for the recombinants. The recipient-only
control was especially important, since it has been reported that lox cassettes can
spontaneously excise as a result of homologous recombination. I did observe that
sequential subculturing of the recipient strain, CSH26Cm::LTL, from a frozen stock,
occasionally yielded Camr, Tets colonies, presumably as a result of homologous
recombination at the lox sites. However, by routinely growing recipients freshly from the 80oC stock, growth of the recipient-only on plates selective for recombinants was rarely
detected.
As reported previously for other T4SSs [33, 65], I observed Cre translocation at very
low frequencies through the pKM101 T4SS independent of fusion to an effector protein.
However, Cre transfer was detected only in a few of the many repetitions of these
experiments, and in these cases only at frequencies in the range of ≤10-7 Recombinants per
donor (Rc’s/D) when using the original recipient and ~10-8 Rc/D when using the Rifr
recipient. This low frequency of transfer establishes a threshold above which translocation
of Cre was considered to be mediated by the fused effector protein. Finally, as discussed
below, I collaborated with another graduate student, Jay Gordon, to generate a nonpolar
traJ deletion in pKM101. As expected, donor cells carrying pKM101ΔtraJ failed to
conjugatively transfer DNA substrates, and also failed to translocate the Cre-effector
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proteins to recipient cells at detectable frequencies (Figure 4.3A). These findings
established the requirement for an intact pKM101-encoded T4SS for translocation.
The tested effector proteins mediated Cre transfer at frequencies ranging from 1.65 x
10-6 to 8 x 10-9 recombinants per donor (Rc’s/D) (Figure 4.3B). The A. phagocytophilum
effector Ats-1 mediated Cre transfer at the highest observed frequency of 1.65 x 10-6 Rc’s/D,
the A. tumefaciens effector VirE2 mediated Cre transfer at the lowest observed frequency,
and most of the other tested effectors mediated Cre transfer at frequencies of 10-7 – 10-8
Rc’s/D. This variation in transfer frequency could reflect biologically relevant differences in
translocation efficiencies of the different effectors, or be attributable to differences in
stabilities of the fusion proteins or their capacities to engage productively with the
heterologous pKM101-encoded T4SS. Additionally, it is important to note that Nathan
Rosenthal performed CRAfT experiments using the Rifr recipient, whereas I performed the
experiments with the original recipient. While Dr. Christie or myself closely supervised Mr.
Rosenthal and verified his data, any deviations from protocol may have further added to
variance within and between experiments.
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Figure 4.3 Translocation of heterologous T4SS substrates through the pKM101
transfer system.
Known and putative effector genes were fused to cre, and pKM101 dependent protein
translocation into an E. coli recipient was determined by monitoring Cre-mediated excision
of a Tetr gene as described in the Materials and Methods.
A. Translocation of Cre-effector fusion proteins into recipient CSH26Cm::LTL containing
the plasmid pBBR1MCS2-Genr. Black bars, transfer by wild type pKM101 with mean
excision frequency and standard deviations shown; White bar, transfer by
pKM101ΔtraJ. Experiments were performed at least 3 times. The dashed line
indicates the threshold of Cre-only background transfer. ** Excision frequency is
statistically significant from the Cre-only control (P<0.0001) * Excision frequency is
statistically significant from the Cre-only control (P<0.05)
B. Translocation of Cre-effector fusion proteins by the wild-type pKM101 system into
the recipient CSH26Cm::LTL, rifr(pUC4K). Experiments were performed at least 3
times. Cre alone transfer was undetectable using this recipient due to elimination of
any retroactive transfer. ** Excision frequency is statistically significant from the Creonly control (P<0.0001)
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trans-expression of traJ confers elevated substrate transfer
As mentioned above, to confirm that the pKM101 T4SS was responsible for
mediating protein translocation, I constructed and tested the effect of a traJ deletion on
substrate transfer. traJ encodes the T4CP, which functions to link substrates with the
pKM101 transfer channel. In collaboration with another graduate student, Jay Gordon, a
precisely deletion of traJ was generated by recombineering [51, 53]. This technique exploits
the homologous Red recombination system of bacteriophage λ, which can catalyze
recombination between a linear DNA fragment and a sequence of interest with as few as 25
bp’s of homology. Once the traJ deletion mutation (ΔtraJ) was confirmed, I first assayed for
effects on DNA substrate transfer. As shown in Figure 4.4, the pKM101ΔtraJ donor strain
failed to conjugatively transfer the mutant plasmid and an isogenic strain also carrying the
IncQ plasmid, pML122, similarly failed to mobilize IncQ plasmid transfer at detectable
frequencies. To ensure that the ΔtraJ mutation did not exert polar effects on expression of
downstream genes, I expressed the wild-type traJ gene from the PBAD promoter carried on
plasmid pBAD24-Kanr. The complemented donor strains induced for traJ expression
efficiently transferred both the pKM101ΔtraJ and pML122 plasmids, whereas uninduced
cells transferred these plasmids at detectable but very low frequencies (data not shown).
Recently, Dr. N. Whitaker showed that arabinose induction was required for detection of Histagged TraJ in membrane extracts of these donor strains by western blotting and
immunostaining with anti-His antibodies, and that presence of the N-terminal His-tag does
not hinder transfer of the pKM101 derivative or pML122 upon induction (data not shown).
Taken together, the above findings establish that synthesis of TraJ is essential for
plasmid transfer through the pKM101 T4SS. Interestingly, arabinose-induction of traJ from
pBAD24-Kanr consistently yielded transfer of both pKM101ΔtraJ and pML122 at frequencies
of ~1 order of magnitude higher than observed with wild-type pKM101 (Figure 4.4). While I
was unable to directly compare steady-state levels of TraJ produced from the PBAD promoter
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and its native promoter, I suspect that synthesis from the strong PBAD promoter yielded
higher amounts of TraJ than from pKM101. If so, synthesis of the TraJ substrate receptor
for the pKM101 T4SS might be a rate-limiting step in the process of conjugative DNA
transfer.
I next tested whether trans-expression of traJ in a pKM101ΔtraJ donor strain
supported transfer of the Cre-effector fusion proteins. Interestingly, several of the fusion
proteins transferred at considerably higher levels than observed with the native pKM101
system (Figure 4.5). Most strikingly, donor strains translocated the WD0811 and WD0830
fusion proteins at frequencies nearly 10-5 and 10-4 Rc’s/D, respectively, as monitored by
CRAfT. Donor strains producing the other fusion proteins also exhibited elevated transfer
frequencies compared with the wild-type system. Additionally, when Nathan Rosenthal
used the Rifr recipient in recent experiments, translocation of most effectors was detected at
approximately 10-6 to 10-4 Rc’s/D with transfer of Cre alone reduced to 1.0 x 10-8 Rc’s/D. Of
further interest, translocation of Cre alone occurred at a frequency slightly above that
observed with the wild-type system with both recipients. Nevertheless, the transfer
frequency of Cre alone remained considerably less than those of the Cre-effector fusion
proteins. Based on these findings, I propose that trans-expression of traJ from the strong
PBAD promoter on multicopy pBAD24-Kanr confers elevated transfer of both DNA and protein
substrates through the pKM101 transfer channel.
Finally, it should be noted that although I detected translocation of the Cre-VirE2
fusion protein, previous work has shown that VirE2 requires its secretion chaperone VirE1
for translocation through the A. tumefaciens VirB/VirD4 T4SS. VirE1 is not required for
substrate docking with VirD4 but instead prevents VirE2 from self-aggregating. In future
studies, it will be of interest to determine if VirE1 coproduction confers Cre-VirE2
translocation in the pKM101 system at higher frequencies than observed in the present
studies.
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Figure 4.4 Effects of a pKM101 traJ deletion and complementation with heterologous
virD4 genes on DNA substrate transfer.
E. coli donor cells carrying pKM101 or pKM101ΔtraJ lacking or expressing the genes
indicated were tested for pKM101 transfer and mobilization of the IncQ plasmid, pML122, to
E. coli recipients. Transfer frequencies are reported as transconjugants per donor.
Experiments were repeated at least 2 times in duplicate and the mean transfer frequencies
with standard deviations are shown. WT, pKM101; ΔtraJ, pKM101 deleted of traJ, and
ΔtraJ expressing traJ and virD4 homologs. * Substrate transfer was statistically significant
from wild-type.
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Figure 4.5 Transfer of heterologous T4SS substrates through the E. coli pKM101
transfer system. Protein transfer was performed as described in Materials and Methods by
using E. coli containing pKM101ΔtraJ and plasmids expressing cre fusions and traJ. Cre
only was used as a negative control, with the dashed line indicating the threshold of Cre
background transfer.
A. Translocation of Cre-effector fusion proteins into recipient CSH26Cm::LTL containing
the plasmid pBBR1MCS2-Genr. Experiments were repeated at least 2 times in
duplicate with the mean excision frequency and standard deviations shown.
* Excision frequency is statistically significant from the Cre alone control (P<0.05)
B. Translocation of Cre-effector fusion proteins by the pKM101 system expressing traJ
from the multicopy plasmid, pBAD24-Kanr, into the recipient CSH26Cm::LTL,
rifr(pUC4K). Experiments were repeated at least 2 times. ** Excision frequency is
statistically significant from the Cre alone control (P<0.0001)
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Do heterologous T4CPs functionally substitute for TraJ in mediating DNA transfer
through the pKM101 transfer system?
In Chapter 3, I determined that the Rickettsia VirD4 homologs did not functionally
substitute for VirD4At in A. tumefaciens. Although these T4CPs might be unstable or fail to
interact productively with the A. tumefaciens VirB channel, it is also possible that the A.
tumefaciens VirB/VirD4 T4SS does not mediate transfer of substrates to other agrobacteria
at frequencies sufficient for detecting functionality of the swapped T4CPs. By contrast, the
highly efficient pKM101 system, supporting plasmid transfer at frequencies exceeding 1
Tc/D, might be sufficient for detection of low-frequency substrate transfer. To test this idea, I
asked whether the VirD4 T4CPs from A. tumefaciens or the Rickettsial species functionally
substituted for TraJ.
I expressed the virD4 genes from A. tumefaciens and W. pipientis from a PBAD
promoter carried on pBAD24 in donor strains carrying pKM101ΔtraJ. Perhaps not
surprisingly, I was not able to detect complementation of the ΔtraJ mutation as monitored by
transfer of pKM101ΔtraJ (Figure 4.4). I next tested for the capacity of isogenic donors for
mobilization of the IncQ plasmid pML122, but again I was unable to detect plasmid transfer
(Figure 4.4). It is important to note that, although there is no evidence for IncQ plasmid
transfer by the native T4SSs carried by W. pipientis, the A. tumefaciens VirB/VirD4 T4SS
mobilizes the transfer of the IncQ plasmid to agrobacterial recipients. In view of these
findings, I envision two possibilities for the failure of the heterologous T4CPs to substitute for
TraJ. First, these T4CPs might be unstable in the E. coli donor cells. Second, they might
fail to interact productively with the pKM101-encoded transfer channel. I examine the
second possibility in more detail in Chapter 5 of this thesis. To address the first possibility,
Dr. N. Whitaker is currently adding His-tags to the heterologous T4CPs to evaluate their
steady-state abundance in arabinose-induced donor cells by western blot analysis.
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In view of my finding above that trans-expression of the Rickettsial T4CPs in wildtype A. tumefaciens conferred diminished substrate transfer through the VirB/VirD4 T4SS, I
tested for poisoning interactions of the heterologous T4CP on functionality of the native
pKM101 T4SS. Interestingly, production of VirD4 subunits from A. tumefaciens or the
Rickettsial species did not abrogate transfer of pKM101ΔtraJ to recipients (Figure 4.6).
These findings are consistent with the proposal that the heterologous T4CPs fail to interact
with the pKM101 T4SS.
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Figure 4.6. Effects of trans-expressed traJ and virD4 homologs on wild type pKM101
self-transfer
E. coli donor cells carrying pKM101 and expressing the genes indicated were tested for
pKM101 transfer to E. coli recipients. Transfer frequencies are reported as transconjugants
per donor. Experiments were repeated at least 3 times in duplicate and the mean transfer
frequencies with standard deviations are shown. WT, pKM101 lacking (-) or expressing the
virD4 homologs shown.
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Do heterologous T4CPs functionally substitute for TraJ in mediating protein transfer
through the pKM101 transfer system?
To further assess the functionality of the chimeric T4SSs, I assayed for translocation
of effector proteins. Specifically, I tested for translocation of the Cre::Ats-1 fusion protein by
donor strains producing the VirD4 T4CPs from A. tumefaciens and the Rickettsial homologs.
Ats-1 was chosen as a test substrate because it consistently transferred at high levels
without much variation, whereas other Cre-effector fusions showed greater inconsistency
between experiments. The chimeric T4SSs were also assayed for transfer of Cre alone as
a control.
As shown in Figure 4.7, pKM101ΔtraJ-carrying donor cells engineered to produce
the VirD4Ap T4CP transferred the Cre::Ats-1 fusion protein at frequencies only slightly lower
than the isogenic donors producing native TraJ. This donor did not translocate Cre alone at
detectable frequencies. The VirD4Ap T4CP is thus capable of engaging productively with the
pKM101-encoded T4SS to mediate translocation of the cognate Ats-1 effector to E. coli
recipient cells. These findings established that Ats-1 engages productively with two
heterologous T4CPs, TraJ and VirD4Ap, in E. coli. I next tested whether the donor cells
producing other T4CPs, including those from A. tumefaciens, W. pipientis, and R. rickettsii
mediated Ats-1 transfer (Figure 4.7). These donors failed to transfer the Ats-1 fusion protein
at detectable levels.
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Figure 4.7 Cre-mediated transfer of Anaplasma effector protein Ats-1 through
pKM101-based chimeric T4SSs
Transfer of Anaplasma T4SS substrate Ats-1 between bacterial cells. Ats-1 Transfer of Cre
fused to Ats-1 by donor E. coli cells carrying pKM101ΔtraJ and expressing virD4 genes from
A. tumefaciens and Rickettsial species was monitored by Cre-mediated excision of a TetR
gene as described in Materials and Methods. Cre-only was used as a negative control.
Experiments were repeated at least 2 times with mean excision frequencies and standard
deviations shown. * Excision frequency was statistically significant from the Cre-only control
(P<0.0001)
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Discussion

The TraJ T4CP is essential and rating limiting for pKM101 and IncQ plasmid transfer.
The conjugative plasmid pKM101 has long been known to transfer itself between E.
coli cells via a T4SS similar to that of the VirB/VirD4 system of A. tumefaciens. This transfer
is mediated by interactions of VirD4-like TraJ, with the relaxasome components [43, 64, 69].
This was confirmed with the creation of a clean deletion mutant of traJ in pKM101, which
was found to completely abolish conjugal transfer of the plasmid. Importantly, this mutant
could be complemented with trans-expressed traJ, indicating the deletion had no polar
effects on the remainder of the Tra operon. In addition to conjugative self-transfer, I
determined that the T4SS of pKM101 also mobilizes the IncQ plasmid, pML122. Even with
lower frequency of transfer at 10-2-10-3 Tc/D for an overnight mating, this is a novel substrate
of this system. Furthermore, I showed that transfer of IncQ is TraJ-dependent, since IncQ
transfer was also completely abolished in pKM101ΔtraJ.

Protein translocation through the conjugative T4SS of pKM101: a novel finding
The T4SS encoded on plasmid pKM101 has been sequenced in its entirely [64], and
to date no proteins have been shown to be translocated through this system exclusive of
relaxasome components in complex with DNA. Although the interactions between coupling
proteins and relaxasome components have been shown to be very system specific [9],
interactions with protein effectors seem to be less specific as shown by transfer of
heterologous proteins through the pKM101 system. Based on these findings, it is possible
that the T4CPs of the T4SSs recognize general features of protein substrates such as Cterminal hydrophobic tails or clusters of positively charged residues, or internal motifs of
unspecified sequence composition or secondary structure.
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Previous studies have identified potential signal sequences in the C-terminal 50
residues of some effectors. Specifically, Vergunst, et al. demonstrated in 2000 that the Cterminal 37 residues of VirF in A. tumefaciens were sufficient for translocation into recipient
cells indicating the possible presence of a transport signal [5]. Further comparison with the
amino acid sequence of the effector VirE2, revealed a conserved R-P-R motif in this region.
Another study showed that the C-terminal 50 residues of VirE2 and VirE3 were sufficient for
effective transfer using the CRAfT assay [65], providing further support of a C-terminal
transport signal. Later studies of these C-terminal regions identified the C-terminal 19
amino acids to be adequate for transfer of VirF, and identified a consensus sequence of RX(7)-R-X-R-X-R-X-X(n)> upon comparison to other effectors [66].
Examination of the C-terminal regions of the effectors presented in this thesis
indicated that the R-P-R or R-X(7)-R-X-R-X-R-X-X(n)> signal sequences previously
identified were not present in the Anaplasma or Wolbachia effectors (Figure 4.8A). Previous
examination of the Ats-1 C-terminal 20 residues revealed a greater abundance of positively
charged residues relative to the remainder of the protein [46]. Indeed, examination of the Cterminal 30 residues yielded a net positive charge of +1.2 at pH 7.0 for Ats-1, while
Aph_0111, WD0636, and WD0830 all had net charges of -0.1. WD0811 yielded a net
positive charge of +2.2 in this region (Figure 4.8B).
While positively charged residues in the C-termini have been shown to be important
for substrate recognition, other factors must also be necessary. As demonstrated above,
expression of Ats-1 CTD yielded consistently less transfer than full-length Ats-1 through the
native pKM101 system, suggesting that other domains may be necessary for efficient
transfer through this heterologous system. Similarly, WD0636 and WD0830 transferred at
rates similar to effectors carrying charged C-termini, indicating these effectors are using
another means of recognition. As shown above, sequence alignment and analysis of the C-
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terminal 30 residues does not reveal any conserved sequence or motif among these
proteins.
In Chapter 3, I hypothesized that the CTE of VirD4At played a role in recognition of
effector proteins, since deletion of the CTE allowed transfer of IncQ but abolished plant
tumorgenesis. Additionally, I suggested that conjugation T4SSs such as pKM101 do not
have a CTE because they translocate DNA but not protein substrates. However, the finding
that TraJ is able to transfer heterologous proteins in the absence of a CTE, indicates that
translocation of these proteins is not dependent on interaction with a C-terminal extension.
It is possible that CTE’s carried by other T4CPs play a modulatory role, such as mediating
transfer of specific substrates, enhancing transfer of some substrates by promoting
substrate-T4CP contacts or coordinating the timing of transfer of numerous substrates
through a T4SS. The function of the CTE is addressed further in Chapter 5.

	
  

75	
  

	
  

Figure 4.8 Analysis of the effector C-terminal tails
A. Sequence alignment of the C-terminal 30 residues of the A. tumefaciens effectors
VirE2, VirE3, and VirF indicating a conserved R-P-R motif (top), and the Anaplasma
and Wolbachia effectors presented in this thesis (below). Alignment of the
Rickettsial effectors show the R-P-R or R-X(7)-R-X-R-X-R-X-X)n> signal sequences
previously identified are not present in these effectors.
B. C-terminal 20 residues of the A. tumefaciens and Rickettsial effectors. Positively
charged residues are identified in bold print, while hydrophodic residues are
underlined. Overall charge and pI of the protein fragment are indicated.
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Effector

Sequence

Charge

pI

VirE2!

ISDSRRIYESRPRSQSVNSF !

+2.9!

11.31!

VirE3!

ARSMIFEGSRPRERSTSRGF !

+4.9!

11.83!

VirF!

HDDARAELMSADRPRSTRGL !

+3.2!

11.31!

Ats-1!

VTPLVSAQNRGPETHGKGTR !

+1.2!

9.06!

Aph_0111! KENAFSEVMKGRGTFTTISG !

-0.1!

6.25!

WD0636!

EVTEVLKKETDRIEKLFEKL !

-0.1!

6.62!

WD0811!

QIRGGTTLKRVGSNKILQMN !

+2.2!

10.00!

WD0830!

LDQPSAEPVNSRATATPGTV !

-0.1!

6.25!
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A chimeric T4SS composed of homologous T4CPs and the pKM101 encoded mating
channel
It has been shown that T4CPs are able to form stable interactions with channel
subunits from non-cognate T4SS [9], and that they are able to interact with and transfer noncognate protein effectors into target cells [22]. Therefore, we wanted to explore the use of
pKM101 as a chimeric T4SS for the transfer of DNA and protein substrates. Genes
encoding full-length coupling proteins from either A. tumefaciens or Wolbachia were
expressed in E. coli containing pKM101ΔtraJ. These homologous T4CPs failed to support
transfer of pKM101 or the IncQ plasmid. As mentioned above, pKM101 is not a natural
substrate for the A. tumefaciens or Wolbachia T4SSs, although the A. tumefaciens system
does transfer the IncQ plasmid to other agrobacteria. The lack of transfer of any DNA
substrate by the chimeric T4SSs could be due to instabilities of the T4CPs in E. coli, or a
failure to engage properly with the pKM101-encoded secretion channel. Recall that in the A.
tumefaciens VirB/VirD4 system, the Rickettsial T4CP genes conferred negative dominance
when expressed in wild-type strain A348, suggesting that the T4CPs somehow poison
substrate transfer through the VirB/VirD4 T4SS. In the E. coli pKM101 system, expression
of the heterologous T4CPs did not exert negative dominance. From these experiments, no
conclusions can be drawn regarding the capacity of the heterologous T4CPs to engage
productively or nonproductively with the pKM101 system or its DNA substrates. In the next
chapter, however, I describe results of experiments showing that the heterologous T4CPs in
fact can function to mediate substrate transfer when their N-terminal transmembrane
domains are substituted with that of TraJ.

	
  

78	
  

	
  

Chapter 5. The Development of Chimeric Coupling Proteins in an Effort to Enhance
Substrate Transfer Through a Surrogate T4SS
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Introduction
The Tra type IV secretion system of pKM101 translocates DNA substrates including
pKM101 and mobilizable IncQ plasmids to other bacterial cells through a process requiring
direct cell-cell contact [43]. This transfer system consists of a secretion channel and the
type IV coupling protein (T4CP) termed TraJ, the latter of which physically joins secretion
substrates to the transfer channel. Previous studies have shown that some T4CPs can be
substituted for another and mediate transfer of IncQ plasmids through the heterologous
T4CP [9, 23]. As reported in Chapter 4, substitution of A. phagocytophilum VirD4 for
pKM101-encoded TraJ supported translocation of the effector protein Ats-1 through the
pKM101 secretion channel. However, I was unable to create chimeric systems capable of
mediating DNA transfer by substituting Rickettsial T4CPs for VirD4 in the A. tumefaciens
system or heterologous T4CPs for TraJ in the E. coli pKM101 system.
As mentioned earlier, the T4CPs are composed of several distinct domains, the Nterminal transmembrane domain (TMD), nucleotide binding domain (NBD), all-alpha domain
(AAD), and in some cases a C-terminal extension (CTE). There is some evidence that the
TMDs mediate interactions of T4CPs with one or more subunits of the transfer channel,
whereas one or more of the other domains mediate interactions with secretion substrates [9,
12, 23, 45, 70-73]. I thus hypothesized that the failure of the Rickettsial and A. tumefaciens
T4CPs to mediate substrate transfer through the pKM101 translocation system is due to the
inability of the respective TMDs to engage productively with the pKM101 channel subunits.
To test this hypothesis, I asked whether chimeric coupling proteins composed of the TMD of
TraJ and the remaining domains from the A. tumefaciens or Rickettsial T4CPs would
mediate substrate transfer (Figure 5.1).
Overall, this line of study was intended to: i) test whether the TMD mediates the
T4CP-channel interaction, ii) enhance the efficiency of heterologous protein substrate
transfer through the pKM101 transfer system over that achieved with the native pKM101
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system, and iii) test the importance of the C-terminal domain of A. tumefaciens VirD4 for
recognition of A. tumefaciens protein substrates. My work also was intended to generate
the molecular tools necessary for longer-term studies aimed at testing whether chimeric
systems can be used to identify novel protein substrates of the Rickettsial VirB/VirD4 T4SSs
that fail to translocate through the native pKM101 system.
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Figure 5.1 Schematic of chimeric coupling proteins
Diagram illustrating the domain organization of the different chimeras. The TMD of TraJ is
represented on the left in yellow, with the various soluble domains on the right. The
numbers represent the amino acid residue at the beginning or end of the domain. The
different domains are identified at the top: TMD, trans-membrane domain; AAD, all-alpha
domain; NBD, nucleotide binding domain; CTE, C-terminal extension.
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Results

DNA substrate transfer using chimeric coupling proteins
Chimeric proteins were constructed by combining the TMD of TraJ with the SD of
another VirD4-like coupling protein. Dr. N. Whitaker created two chimeras by joining the
TraJ TMD with the A. tumefaciens VirD4 soluble domain (SD). Plasmid pNW2 expresses a
gene encoding TraJ::VirD4At and pNW4 expresses a gene encoding TraJ::VirD4AtΔ553,
which is deleted of VirD4’s C-terminal extension (Table 2.1, Figure 5.1). Upon expression of
both chimeric genes in pKM101ΔtraJ, conjugative transfer of pKM101 was not detected
(Figure 5.2). However, we did observe mobilization of the IncQ plasmid at frequencies
slightly below those observed for IncQ plasmid transfer by wild type pKM101. Dr. Whitaker
also made a TraJ::VirD4At chimera deleted of its AAD (TraJ::VirD4AtΔAAD; pNW6), and this
chimera was not able to translocate pKM101 or the IncQ plasmid. These findings establish
that the TraJ::VirD4At chimera is fully functional for translocation of the promiscuous IncQ
plasmid. Furthermore, VirD4At’s SD is not capable of engaging or delivering the pKM101
substrate through the translocation channel. Finally, as reported with the A. tumefaciens
system, VirD4At’s CTE is not important for IncQ plasmid transfer to recipient bacteria. By
contrast, the AAD is essential for all plasmid substrate transfer.
I followed this up by creating chimeric coupling proteins containing the SDs of
Rickettsial homologs (Table 2.1, Figure 5.1). TraJ::VirD4Ap (pTB39) and TraJ::VirD4Wp
(pTB51) were tested for their ability to mediate pKM101 and IncQ plasmid transfer through
the VirB channel. As shown in Figure 5.2, neither chimera supported DNA substrate
transfer, indicating that the SDs of these chimeric proteins do not engage productively with
or deliver the DNA substrates to the transfer channel. Another possibility is these chimeric
proteins are unstable in E. coli.
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Figure 5.2 Conjugative transfer of pKM101 and the IncQ plasmid pML122 between E.
coli cells
Conjugative transfer mediated by T4SSs composed of the pKM101-encoded transfer
channel and traJ or chimeric coupling proteins. Deletion of the all-alpha domain (AAD;
residues 186-298) of TraJ or the chimeras show abolished substrate transfer. Experiments
were repeated at least 2 times; results are reported as mean frequency of transfer with
standard deviations indicated. WT, pKM101; ΔtraJ, pKM101 deleted of traJ; pKM101ΔtraJ
expressing traJ, traJΔAAD, or the indicated chimeras. * Substrate transfer is statistically
significant from wild-type (P<0.0001)
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Protein effectors are translocated by the pKM101 system via a chimeric coupling
protein
Next, I tested whether the chimeric T4CPs mediate transfer of effector proteins. E.
coli strain MS411 carrying the Cre-effector expression plasmids and pKM101ΔtraJ served
as donors and CSH26Cm:LTL(pBBR1MCS2-Genr) served as the recipient. As shown in
Figure 5.3, donor strains producing the TraJ::VirD4At chimeric coupling protein translocated
the A. tumefaciens effector VirF at frequencies of 3 x 10-8 Rc’s/D, whereas the isogenic Creonly donor failed to translocate Cre at detectable frequencies. Donor strains producing the
TraJ::VirD4At chimera failed to translocate Cre::VirE2 or Cre::VirE3 at detectable levels.
However, in more recent work, Nathan Rosenthal in the Christie lab showed that Cre-VirE2
was translocated at ~10-6 Rc’s/D when the secretion chaperone VirE1 was coproduced in
the donor cells (data not shown). These findings are consistent with previous reports
showing that VirE1 is essential for translocation of VirE2 through the A. tumefaciens
VirB/VirD4 T4SS.
The above findings prompted further tests of chimeric T4CPs composed of TraJ’s
TMD and SDs from A. phagocytophilum and W. pipientis. I was interested in testing
whether codon optimization of the SD from A. phagocytophilum VirD4 enabled substrate
transfer, and to this end I sent the TraJ::VirD4Ap chimera to Invitrogen for codon optimization
and artificial synthesis using their GeneArt® technology. I then generated plasmids
expressing genes for the TraJ::VirD4Ap chimeric T4CP as well as this T4CP deleted of its Cterminal extension designated as TraJ::VirD4ApΔ574. Donor strains carrying pKM101ΔtraJ,
pTB39 which produces TraJ::VirD4Ap, and plasmids producing the Rickettsial effector fusion
proteins were assayed for protein transfer by CRAfT. Interestingly, I was able to detect
translocation of several of the Cre-effector fusions (Figure 5.4). The Cre::Ats-1 and
Cre::Aph_0111 fusion proteins were translocated at the highest frequencies of ~2 x 10-7
Rc’s/D. The Cre::Ats-1 CTD and Cre::WD0811 fusion proteins were delivered to recipients
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at frequencies of ~3 x 10-8 Rc’s/D. Cre joined to another putative Wolbachia effector,
WD0636, was translocated but at frequencies only slightly above background levels
observed with Cre only. Recent experiments using the Rifr recipient have shown that the
Anaplasma effectors all transfer at approximately 10-7 Rc’s/D, while the Wolbachia effector
WD0811 has transferred at frequencies approaching 10-6 Rc’s/D (data not shown).
Additional experiments are needed to test transfer of the other substrates using this
recipient.
I also tested for transfer of the Wolbachia effectors by donor cells producing the
TraJ::VirD4Wp chimeric protein (Figure 5.5). Transfer with this chimeric system was rather
weak using the original recipient with Ats-1, WD0636, and WD0811 transferring at levels
only slightly above Cre alone. Interestingly, this chimeric system supported a much more
robust excision frequency with the Rifr recipient, where background is nearly undetectable.
This system was able to transfer Cre::Ats-1 and Cre::Ats-1 CTD and frequencies of ~10-6
and Cre fused to the three Wolbachia effectors at frequencies between 10-7 and 10-6 Rc’s/D
(data not shown). Again, further experiments are required to test the remaining effectors
with the Rifr recipient.
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Figure 5.3. Protein translocation between E. coli cells mediated by T4SSs composed
of the pKM101-encoded transfer channel and the Tra::VirD4At T4CP.
A. tumefaciens effectors of the VirB/VirD4 T4SS were fused to Cre and tested for
translocation to recipient cells carrying a lox-tetr-lox cassette, as described in Materials and
Methods. Donor strains produced TraJ::VirD4At (black bars) or TraJ::VirD4AtΔ553 (white
bars). Experiments were repeated at least 2 times and results are reported as mean
frequency of Cre-mediated excision, with standard deviations indicated. * Excision
frequency is statistically significant compared to the Cre-only control (P<0.0001) ** Excision
frequency is statistically significant with deletion of the CTE (P<0.0001)
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Figure 5.4. Interbacterial protein transfer using chimeric coupling proteins with the
soluble domain from A. phagocytophilum
T4SSs composed of the pKM101-encoded transfer channel and the Tra::VirD4Ap T4CP were
assayed for translocation of Cre fused to putative T4SS effectors from Rickettsial species.
Donor strains produced TraJ::VirD4AP (black bars) or TraJ::VirD4WpΔ574 (white bars).
Experiments were repeated at least 2 times, and results are reported as mean frequency of
Cre-mediated excision, with standard deviations indicated. ND, experiments were not done.
* Excision frequency is statistically significant compared to the Cre-only control (P<0.05) **
Excision frequency is statistically significant with deletion of the CTE (P<0.05)
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Figure 5.5 Interbacterial protein transfer using chimeric coupling proteins containing
the soluble domain from W. pipientis
T4SSs composed of the pKM101-encoded transfer channel and the Tra::VirD4Wp T4CP
were assayed for translocation of Cre fused to putative T4SS effectors from Rickettsial
species. Donor strains produced TraJ::VirD4Wp (black bars) or TraJ::VirD4WpΔ574 (white
bars). Experiments were repeated at least 3 times, and results are reported as mean
frequency of Cre-mediated excision, with standard deviations indicated. * Excision
frequency is statistically significant compared to the Cre-only control (P<0.0001) ** Excision
frequency is statistically significant with deletion of the CTE (P<0.0001)
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The T4CP CTE modulates effector translocation
As shown earlier in this thesis, in A. tumefaciens the VirD4At deleted of its CTE did
not alter translocation of the IncQ plasmid to agrobacterial recipients but abolished T-DNA
transfer to plants. Similarly, in E. coli, the TraJ::VirD4At and TraJ::VirD4AtΔCTE chimeras
supported IncQ plasmid transfer but not pKM101 through the pKM101 transfer channel.
These findings established that VirD4’s CTE contributes to translocation of DNA substrates
native to the cognate T4SS, but not to the promiscuous IncQ plasmids. I next tested
whether the CTE of VirD4At contributes to effector protein transfer. Interestingly, although I
did not see any effect of deleting the CTE on translocation of VirE2 or VirE3, translocation of
VirF was dramatically enhanced (Figure 5.3). This suggests that the CTE of VirD4At plays
an inhibitory role in VirF translocation.
CTE deletions of Anaplasma and Wolbachia chimeras, TraJ::VirD4ApΔ574 and
TraJ::VirD4WpΔ574, were also examined for their ability to translocate the Cre-effector
fusions. Donor cells producing the TraJ::VirD4ApΔ574 chimera translocated the Ats-1 and
Ats-1 CTD effectors at higher frequencies than donors producing the full-length chimera
(Figure 5.4). However, translocation of Aph_0111 was abolished, suggesting that the CTE
is important for translocation of this putative effector. Donor cells producing the
TraJ::VirD4WpΔ574 chimera failed to translocate the A. phagocytophilum effectors and also
the Wolbachia putative effectors, with the exception of WD0811, which transferred at
approximately the same frequency as the system composed of the TraJ::VirD4Wp chimera
(Figure 5.5). Experiments are still being completed to examine the effects of CTE deletion
using the Rifr recipient.
Taken together, results of these studies establish that the CTE of A. tumefaciens
VirD4 contributes to translocation of cognate T-DNA substrate, and possibly effector
proteins, to plant cells. However, the CTE is not important for IncQ plasmid in either A.
tumefaciens or E. coli, and in E. coli VirD4At’s CTE also negatively affects translocation of
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the protein effector VirF. The CTE’s of the A. phagocytophilum and W. pipientis effectors
modulate - either positively or negatively - translocation of effector proteins. Of particular
interest, VirD4Ap’s CTE disrupts Ats-1 transfer, but is essential for translocation of
Aph_0111. VirD4Wp’s CTE was shown to be required for transfer of Ats-1 and dispensable
for transfer of WD0811, however interpretation of these results were inconclusive due to
overall low excision frequencies.

Discussion

Chimeric coupling proteins retain the ability to translocate a variety of substrates in a
surrogate T4SS
Although previous studies showed that chimeric T4SSs composed of a T4CP from
one system and the channel subunits from another are functional [9, 20, 22], my work has
shown for the first time that T4SSs composed of chimeric coupling proteins are functional.
The goal of these studies was to determine whether such chimeric systems would support
translocation of cognate and non-cognate substrates with higher sensitivity and higher
efficiency than observed for the native pKM101 system. If such a system could be
designed, it would greatly improve our ability to identify and study substrates from
pathogens that are known to contain T4SSs but are difficult to grow or genetically
manipulate. Additionally, such systems will allow for further detailed studies aimed at
identifying specific T4CP domains of functional importance as well as motifs or domains
required for substrate-T4CP engagement. In the previous chapters, I demonstrated that the
pKM101 T4SS transfers known and putative substrates, including an IncQ plasmid, the A.
phagocytophilum effector Ats-1, and other effectors from Wolbachia and A. tumefaciens.
Here, I showed that various chimeric T4CPs supported DNA or effector protein transfer,
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although not at levels higher than native pKM101 system or the pKM101 system
presumptively overproducing the TraJ T4CP.
Fusion of TraJ’s TMD with the SD of VirD4At resulted in a chimera that supported
transfer of the IncQ plasmid and the A. tumefaciens effector VirF. It is noteworthy that this
system translocated the IncQ plasmid at frequencies comparable to native pKM101, yet it
failed to translocate pKM101 at detectable frequencies. This suggests that VirD4At’s SD
contains specific sequence information or a structural fold necessary for productive
engagement with the IncQ plasmid substrate. By contrast, this SD lacks the interaction
domain necessary for engagement with the pKM101 substrate. My finding that the
TraJ::VirD4At chimera supported VirF translocation established that VirD4At’s SD also carries
the motif necessary for engagement with this substrate.
VirF is not known to require a secretion chaperone for translocation through the
VirB/VirD4 T4SS. By contrast, VirE2 requires its chaperone VirE1 and it appears that my
inability to detect VirE2 translocation was because the donor strain used in my studies did
not produce VirE1. Nathan Rosenthal, a Rice University undergraduate student,
demonstrated that VirE1 coproduction with Cre-VirE2 supported transfer of the fusion
protein (data not shown). Together, these findings established that the TraJ::VirD4At chimera
supports transfer of both chaperone-independent and –dependent effector proteins. The A.
tumefaciens VirB/VirD4 T4SS translocates T-DNA and effector proteins to yeast cells, as
well as to plant cells as a part of the infection process. It will be interesting in future studies
to test whether the E. coli pKM101 system with the TraJ::VirD4At chimera also supports
transfer of T-DNA substrates to E. coli or eukaryotic recipient cells.
I was also able to demonstrate translocation of Cre-effector fusion proteins through
pKM101 systems relying on the TraJ::VirD4Ap and TraJ::VirD4Wp chimeras. The former
supported transfer of the A. phagocytophilum effectors in addition to WD0636 and WD0811
from Wolbachia, whereas the latter was more rigid in its capacity to bind and mediate
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translocation of most of the A. phagocytophilum and Wolbachia effectors. With the
exception of their variable CTE’s, the VirD4Ap and VirD4Wp SD’s are highly similar in overall
sequence composition (78% identity). As discussed further below, these observations
suggest that the CTE’s of these T4CPs may play important roles in substrate selection and
translocation modulation.

The roles of the AAD and CTE in type IV secretion.
An important goal of these experiments was to assign functional importance to the
T4CP domains. For example, although the native T4CPs from A. tumefaciens and
Wolbachia did not mediate translocation of any tested substrates, the corresponding
chimeric proteins composed of the TraJ TMD joined to the SD’s of these T4CPs supported
translocation of at least some substrates. These findings strongly indicate that the TMD of
TraJ is critical for productive interactions with the rest of the pKM101 transfer machinery.
This finding is consistent with a previous study in which mutations in the TMD of R388encoded TrwB abolished the capacity of this T4CP to mediate DNA transfer and also
disrupted an interaction with the VirB10-like subunit TrwE [9].
The functionality of the chimeric T4CPs further suggested that SD’s of the T4CP
confer both substrate binding and specificity. The SD’s of A. tumefaciens, A.
phagocytophilum, and W. pipientis are composed of three smaller domains, the NBD’s,
AAD’s, and CTE’s. Here we have shown that the AAD’s of both TraJ and VirD4At are
required for translocation of DNA substrates in the pKM101 system. Dr. N. Whitaker has
expanded this study to show this domain is also required for translocation of protein
substrates in the pKM101 system, as well as DNA and protein substrates in the A.
tumefaciens system (data not shown). He has also shown that the AAD domain of VirD4At
binds DNA and also interacts with VirE2. These findings suggest that the AAD’s of T4CPs
play a role in substrate binding and translocation. Interestingly, however, the AAD’s of VirD4
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proteins from A. phagocytophilum and W. pipientis are highly similar, suggesting that these
domains probably are not solely responsible for mediating binding of the different effectors
translocated through these Rickettsial species. However, the CTE’s of these proteins as
well as the CTE of A. tumefaciens, are highly variable in sequence composition and overall
charge. In view of these observations, I tested a hypothesis that the T4CP CTEs contribute
to substrate transfer.
TraJ::VirD4At was the only chimeric T4CP of those tested that supported DNA
transfer through the pKM101 transfer system (Figure 5.2). Deletion of VirD4’s CTE had no
effect on IncQ plasmid transfer, establishing that this domain is not important for transfer of
this promiscuous plasmid. This conclusion is further supported by the fact that pKM101encoded TraJ lacks a CTE and yet transfers the IncQ plasmid at frequencies similar to that
of donor cells producing TraJ::VirD4AtΔ533.
In general, deletions of the CTEs associated with VirD4At, VirD4Ap, and VirD4Wp had a
range of effects on effector protein translocation. For example, donor cells producing
TraJ::VirD4AtΔ533 transferred Cre-VirF at higher frequencies than donors producing
TraJ::VirD4At (Figure 5.3). Similarly, cells producing the VirD4Ap chimera deleted of its CTE
translocated the Ats-1 and Ats-1 CTD effectors at a higher frequency than cells producing
the full-length chimera. In view of my finding that trans-expression of traJ in a pKM101ΔtraJ
donor conferred elevated DNA transfer frequencies compared to the native pKM101 system,
it is formally possible that the CTEs deletions enhanced stabilities of the T4CPs and that the
higher amounts of the chimeric T4CPs correlated with higher transfer frequencies. I suspect
this is not the case, however, because strains producing the VirD4Ap and VirD4Wp chimeras
with CTE deletions did not always confer elevated effector protein translocation. For
example, TraJ::VirD4ApΔ574 did not support translocation of the Aph_0111 putative effector
at detectable levels. Additionally, TraJ::VirD4WpΔ574 translocated WD0811 at similar levels
to the full-length chimera. My data suggest, therefore, that the CTEs modulate translocation
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of effector proteins in different ways, in some cases enhancing transfer while in other cases
impeding or completely blocking transfer. Additional experiments are being done to explore
the effects of CTE deletions using the Rifr recipient. It will be especially interesting to see
these effects with TraJ::VirD4WpΔ574 since transfer frequencies seems to be generally
higher using this recipient and any effects should be more obvious.
To reconcile these diverse findings, it is interesting that the CTE’s of the T4CPs
under study varied in length and overall negative charge. CTE’s with these physical
properties could be important for binding of some substrates, but dispensable for binding of
others. Also, it is important to note that, although the E. coli pKM101 system in general
appears to be a useful surrogate for monitoring transfer of heterologous T4SS effectors, it
also has several limitations. E. coli is a different genetic context than A. tumefaciens, A.
phagocytophilum or W. pipientis, and therefore might lack important adaptors or chaperones
necessary for proper presentation of the effectors to the T4CP. The absence of these
auxiliary factors could affect how the CTE participates in substrate engagement.
Finally, it is remarkable that the VirD4Ap and VirD4Wp chimeric T4CP CTEs are very
long (166 and 102 residues, respectively) and highly-negatively charged. It is possible that
the long CTEs adopt a structural fold within the T4CP that modulates the binding of some
effector proteins that form charge-based contacts with the T4CP. In this context, it is
interesting that the VirD4Ap and VirD4Wp chimeras did not support transfer of the mobilizable
IncQ plasmid. Conceivably, the CTE’s of these proteins block engagement of the T4CP with
DNA substrates by establishing charge-based interactions with a binding interface of the
T4CP that alternatively could bind DNA. If so, the CTE’s would essentially function as a
DNA mimic. In the natural A. phagocytophilum and W. pipientis hosts, the CTE’s might
function as substrate specificity determinants by selectively blocking DNA translocation
while promoting delivery of a repertoire of effector proteins into the mammalian cytosol to
aid in infection.
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Chapter 6: Summary and Perspectives
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Summary
Type IV secretion systems are large complex machines, composed of a dynamic
arrangement of 11 VirB proteins along with the coupling protein, VirD4 [1, 4]. These
machines assemble across cell membranes to form an expansive secretion channel for the
transport of macromolecules across the cell envelope and into the extracellular environment
or other cells [1]. This thesis is focused on enhancing our understanding of substrate
specificity and recruitment to the T4S channel, through interactions with the VirD4-like
coupling proteins, and development of a chimeric translocation system. I hypothesized that
transfer of non-cognate effector substrates could be observed through a chimeric T4SS, and
that the CTE of VirD4-like coupling proteins are functionally important for the transfer of
protein effectors.
In chapter 3, I demonstrated that, while the A. tumefaciens T4SS did not serve as an
efficient chimeric system for transfer of A. tumefaciens effectors or the IncQ plasmid,
homologous T4CPs seemed to be interacting with components of the T4SS, as indicated by
a “poisoning” phenotype. This was measured through a reduction of virulence and IncQ
transfer when homologous VirD4 proteins were produced in a wild-type strain, which also
produced the native coupling protein. While we were unable to confirm expression of the
homologous coupling proteins, this experiment provided evidence that the proteins were
produced in sufficient amounts to cause a disruption in substrate transfer.
Functional analysis of the CTE of VirD4At in A. tumefaciens implied that the CTE
plays a critical role in the transfer of some substrates required for plant virulence, but was
dispensable for the RSF1010 derived IncQ plasmid, pML122. This is comparable to a
previous study that showed the TraD coupling protein, from the F-plasmid, carries a CTE
that is required for F-transfer but inhibitory for RSF1010 transfer [12]. Taken together with
the later evidence provided in chapter 5, showing variable effects of CTE deletion on
chimeric T4CPs, it appears that the CTE may have an operative role in transfer of the

	
  

97	
  

	
  
conjugative Ti-plasmid and a possible modulatory role in transfer of protein effectors. Given
the variable effects observed with deletion of the CTE on effector transfer, further studies
are needed to elucidate the exact function of the CTE in protein transfer and any important
residues, motifs, or structural folds required for interaction.
Chapter 4 examines the capacity of the Tra T4SS, encoded on the E. coli plasmid
pKM101, to serve as a surrogate system for translocating heterologous substrates. Here I
presented data identifying the IncQ plasmid, pML122, as a novel substrate, in addition to
protein substrates from A. tumefaciens and Rickettsial homologs. Cre recombinase based
assays have been widely used for demonstrating transfer of effectors through a T4SS [20,
25, 33]. In this study, I used the Cre-recombinase Reporter Assay for Translocation
(CRAfT) to demonstrate that pKM101 could effectively translocate Cre-effector fusion
proteins into a recipient cell. This was very surprising, as pKM101 had not been examined
for the ability to transfer effector proteins previously. Additionally, I confirmed these proteins
were being transferred in a manner contingent on the presence of TraJ, as a ΔtraJ mutant
showed undetectable transfer of all protein substrates. Interestingly, presumed
overexpression of traJ caused variable increases in transfer of several proteins, especially
the putative Wolbachia effector WD0830 whose expression was undetectable on western
blot. However, use of an improved recipient strain, CHS26Cm::LTL,rifr(pUC4K), showed
less variation in transfer levels.
Also in chapter 4, I examined the use of heterologous T4CPs and a chimeric T4SS in
E. coli. As opposed to previous studies indicating T4CPs are able to interact productively
with non-cognate Mpf proteins [9] or effector proteins[22], I was unable to show functional
substitution of heterologous T4CPs for TraJ in mediating DNA transfer, nor did any of the
heterologous T4CPs produce a “poisoning” phenotype in a wild-type pKM101 background.
Additionally, most of the T4CPs tested were unable to functionally substitute for TraJ in
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mediating protein transfer, with the exception of VirD4Ap, which was able to transfer Ats-1 at
levels similar to those of strains producing TraJ.
In Chapter 5 I focused on trying to enhance substrate transfer through the use of
chimeric coupling proteins, containing the TMD of TraJ and the SD of the different VirD4
homologs [9]. These chimeric coupling proteins were designed based on bioinformatic
examination of homology between the protein sequences. Therefore, it is possible that the
junction points identified may not be optimal for these chimeras. Further bioinformatics
analysis and experimentation are necessary to determine the ideal junctures for these
chimeric proteins, conceivably resulting in more robust transfer.
Based on the data presented, I was able to establish that the TraJ::VirD4At chimera is
functional for IncQ and VirF substrate transfer, at frequencies of ~10-4 Tc’s/D and ~10-8
Rc’s/D, respectfully. Additionally, I tested several domain deletions of TraJ and the
TraJ::VirD4At chimera, prepared by Dr. N. Whitaker, to assess the contributions of the AAD
in substrate transfer, and found that the AAD was required for transfer of both pKM101 and
IncQ. This supports a model that the AAD is involved with the processing of substrates for
transfer [11]. Furthermore, I determined that chimeras made with the VirD4Ap and VirD4Wp
soluble domains were similarly functional for protein translocation, although neither proved
functional for DNA substrate transfer.
Finally, I developed C-terminal deletions in the chimeric T4CPs presented above, to
assess the functional role of the CTE in substrate transfer. While the CTE deletion of
TraJ::VirD4At indicated an inhibitory role for the transfer of VirF, similar to Ats-1 with the CTE
deletion of TraJ::VirD4Ap, the CTE of TraJ::VirD4Ap appears to be required for transfer of
Aph_0111. Similarly, previous studies have indicated the CTE of TraD provides increased
specificity and efficiency with regards to F-plasmid transfer [72]. Furthermore, deletion of the
CTE from TraJ::VirD4Wp had no effect on transfer of WD0811, indicating this effector is likely
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interacting with another region within the VirD4Wp SD. This assortment of results suggests
the CTE may play a modulatory role for the transfer of some, but not all, effector proteins.
The studies presented here were aimed at establishing a ‘proof-of-principle’ for the
use of surrogate or chimeric T4SS’s to identify novel Rickettsial effectors, and to refine our
knowledge of the molecular basis underlying the VirD4 receptor – substrate docking
reaction. Based on the data presented in this thesis, I was able to demonstrate that wildtype pKM101 serves as an adequate surrogate T4SS for transport of non-cognate protein
effectors. Additionally, I determined that a chimeric T4SS in pKM101 was achievable
through the use of chimeric coupling proteins. Lastly, I provided additional evidence that the
CTE of VirD4-like proteins are functionally relevant for transfer of substrates. However, the
functionality of this domain appears to be T4CP and substrate specific.

Comparison of effector translocation through the native and chimeric pKM101
systems
Surrogate T4SSs are currently being used in A. tumefaciens and Legionella
pneumophila to identify novel effector substrates from intracellular pathogens known to
produce a T4SS [20-22]. However, these systems are complicated by prolonged growth
cycles and, in the case of L. pneumophila, requirements of intracellular growth. In this
study, I presented data showing the native pKM101 system serves as a suitable surrogate
for translocation of effector proteins from three different bacteria with frequencies of transfer
ranging from ~10-6 to 10-8 Rc’s/D. Furthermore, presumable overexpression of the T4CP,
TraJ, from the multicopy plasmid pBAD24-Kanr enhances this transfer to nearly 10-4 Rc’s/D
in some cases.
In an effort to improve efficiency of this system, chimeric T4CPs were produced
along with the pKM101ΔtraJ T4SS. While I did not achieve the enhanced efficiency I had
hypothesized, I demonstrated that chimeric T4SSs were functional for protein translocation
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and, in some cases, DNA transfer. Additionally, the results obtained with chimeric T4CPs
strongly suggest that the trans-membrane domain of the T4CP is necessary and sufficient
for interacting with the rest of the translocation channel. This is in agreement with previous
studies that suggest the TMD interacts with the VirB10-like protein of the secretion channel
[9] and the secretion channel as a whole [74]. The use of these chimeric coupling proteins
in the pKM101 T4SS will allow further investigation into the roles of the AAD and CTE in
substrate transfer, as well as identification of the interacting channel subunit.

Future experiments
Experiments in the future should be centered on optimizing the efficiency of the
heterologous or chimeric T4SS. This would include i) reducing background transfer of Cre
only and, ii) determining the optimal junctions for chimeric proteins. Through use of the
improved CRAfT recipient CHS26Cm::LTL,rifr(pUC4K), I have already eliminated
non-specific background, which might have given rise to aberrantly high frequencies of Cre
translocation and translocation efficiencies of other substrates. Members of the Christie lab
are continuing to test the native pKM101 system and the pKM101 T4SS producing chimeric
T4CPs. Additionally, two unanswered questions are being explored: i) What motifs and/or
residues of the T4CP are required for substrate transfer, and ii) what is the role of the CTE
in effector translocation?

What motifs and/or residues of the T4CP are required for substrate transfer?
To further advance our understanding of the coupling protein – substrate interaction,
and perhaps to help build a more effective chimeric T4SS, it would be beneficial to identify
the exact binding interfaces. The data present in this thesis indicates this interaction is
substrate specific. That is, different substrates appear to be dependent on different domains
of the T4CP for transfer. For example, in A. tumefaciens, presence of the VirD4At CTE is
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required for the transfer of the Ti-plasmid and/or effector proteins, but is entirely dispensable
for IncQ transfer.
To test for specific contacts between the T4CP and DNA or protein substrates, I
propose using co-immunoprecipitation (Co-IP) and cross-linking studies as well as a twohybrid system designed for testing interactions within specific protein domains. The goal of
these Co-IP studies is to isolate complexes of T4CP domains with the substrate. Chemical
cross-linking would be used to stabilize any transient or otherwise weak interfaces.
Additional Co-IP with mutant T4CPs deleted of specific domains or motifs, or containing
amino acid substitutions, would further confirm the results by demonstrating a lack of
interaction.
A potential issue with this proposed line of work is that VirD4-like coupling proteins
form homohexamers in a working T4SS [11, 13]. It is likely that this structure is required for
interaction, and any deletion or other alteration that disrupts hexamer formation could give
false data. Additionally, the use of T4CP fragments in Co-IP would not exhibit this hexamer
formation and may not interact with substrates. Therefore, another possible study would
use bioinformatic analysis to identify potential interacting interfaces on the coupling protein
and introduce a series of cysteine mutations to complete cross-linking studies with the
substrate. This has the added benefit of ascertaining the specific residues required for
interaction and translocation of substrates.

How is the CTE contributing to substrate secretion?
The data in this thesis, as well as other studies, have identified the C-terminal
extension on some coupling proteins as playing a functional role in substrate secretion [72,
74]. Additionally, we know that the CTE is not necessarily required, as several T4CPs
function adequately without the presence of this domain (e.g. TraJpKM101 and TrwBF) [74].
The studies presented here indicate that, when present, the CTE can act to either enhance
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or inhibit transfer of both DNA and protein substrates. Furthermore, this interaction between
the substrate and the CTE of the T4CP seems to be very substrate specific.
In order to facilitate the study of the CTE and its contribution to substrate secretion, I
propose making a series of GST fusions with CTEs from several different coupling proteins.
I would then use these to perform a GST pull-down with cell lysates to isolate any interacting
substrates, followed by analysis with SDS-PAGE and eventually mass spectrometry. This
kind of study would also help to identify if there is a particular motif that the CTE requires for
interaction, which would be useful for in silico identification of potential substrates.
This project arose due to interest from those in the Rickettsial field in finding a
surrogate system to confirm that candidate effectors are being translocated through a T4SS.
To that end, I was able to demonstrate that the native pKM101 T4SS is adequate for
translocation of a diverse set of substrates from a variety of bacterial species. Additionally,
the chimeric T4CPs generated provide an additional tool for demonstrating translocation as
well as providing further insight into specific T4CP/substrate interactions. The findings
presented in this thesis should generate great interest from the Rickettsial field and lead to
much fruitful collaboration between the Christie lab and Rickettsial labs.
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